- When & how to use Chloramphenicol?
- Antibiotic chloramphenicol is a kind of chloramphenicol. It's mostly used to treat eye infections (such as conjunctivitis) and ear infections on occasion.
Chloramphenicol is available in the form of eye drops or ointment. These can be obtained through a prescription or from a pharmacy. It's also available as ear drops. This medication can only be used if it has been prescribed by a doctor.
Centurion Healthcare is the most popular Chloramphenicol supplier in Gujarat.
The medication can alternatively be taken as capsules or delivered intravenously (straight into a vein). This is a therapy for dangerous infections that is almost typically administered in hospitals.
Key facts:
● Most adults and children are unaffected by chloramphenicol.
● Using chloramphenicol for most eye infections will usually result in an improvement within two days.
● After a few days, you should start to feel better if you have an ear infection.
● After applying the eye drops or ointment, your eyes may sting for a short while. It's possible that the ear drops will cause some minor discomfort.
● Chloromycetin, Optrex Infected Eye Drops, and Optrex Infected Eye Ointment are some of the brand names.
Centurion Healthcare is an excellent Chloramphenicol supplier in Vadodara.
When & how to use Chloramphenicol?
Chloramphenicol is available in a variety of strengths. Whether you're using eye drops, eye ointment or ear drops, how you administer the medicine depends on what you're using it for.
Put one drop into the afflicted eye every two hours (during waking hours) for the first two days if you're using 0.5 per cent chloramphenicol eye drops. Then every four hours for the next three days, or as directed by your doctor.
Apply 1 per cent chloramphenicol eye ointment to the afflicted eye every 3 hours if you're using it (during waking hours). Do this 3 to 4 times a day, or as directed by your doctor.
Centurion Healthcare is one of the most distinguished Chloramphenicol capsules suppliers in Vadodara.
If you have a more serious infection, your doctor may advise you to use eye ointment at night and eye drops during the day. This is due to the ointment's ability to adhere to the surface of the eye and eyelid while you sleep. Because the eye drops have no effect on your vision, you can go about your day as usual.
If you are looking for the leading Chloramphenicol supplier in Gujarat, Centurion Healthcare is the name you can count on.
Before using the medicine:
● Always wash your hands before (and after) using chloramphenicol to avoid spreading the infection to the opposite eye or ear. Remove the cap just before using your drug and replace it as soon as you've finished.
● Make sure the nozzle does not come into contact with your eye, ear, or skin.
● Take advantage of a mirror to see what you're doing.
● To put drops in your eyes or ears, lean your head back or to the side.
(Added: Tue Oct 26 2021 Hits: 16 Rating: 0.00 Votes: 0) Rate It
- Best Treatment For Carpal Tunnel Syndrome In Karimnagar
- Carpal tunnel syndrome is a common disorder that causes pain, numbness, tingling, and weakness in the hand and wrist. It occurs when there is a high amount of pressure within the wrist on a nerve called the median nerve. This median nerve provides sensation to the thumb, index, and middle fingers, and half of the ring finger. The little finger (the “pinky”) is typically not affected. This median nerve also provides strength to few muscles at the base of the thumb and index finger.
Carpal tunnel: - Carpal tunnel is a narrow passage in the wrist. The bottom and sides of the tunnel are formed by small semi-circular bones called carpal bones. A tissue called ligament forms in the top of the tunnel. The median nerve and tendons pass through this space. These tendons connect muscles in the forearm to bones in the hand. These help the finger and thumb to bend and straighten.
carpel
Who is at risk?
Women are three times more possible to have carpal tunnel syndrome than men. Carpal tunnel syndrome is mostly diagnosed between the ages of 30 and 60. Jobs that involve repetitive finger use, mainly those associated with high force, extreme wrist motions may develop this disorder.
Many factors contribute to the development of carpal tunnel syndromes such as high salt intake, sedentary lifestyle and, obesity. People who work in professions like Manufacturing, Assembly line work, Keyboarding occupations, and Construction work are at greater risk.
Causes:
The carpal tunnel is a narrow passage in the wrist; it is surrounded by bones and ligaments. Tendons run through the carpal tunnel and help the fingers and the median nerve move, which is responsible for both sensation and movement in the hand, thumb, index finger, middle finger, and ring finger.
Any condition that causes swelling of the membranes of the carpal tunnel can lead to the carpel tunnel syndrome. When the tissues of the carpal tunnel become swollen, it will cause the median nerve to be compressed, which is known as nerve entrapment.
Conditions related to carpal tunnel syndrome are:
Diabetes
Thyroid dysfunction
Fluid retention from pregnancy or menopause
High blood pressure
Autoimmune disorders such as rheumatoid arthritis
Fractures or trauma to the wrist
Wrist fracture or dislocation
Wrist Deformity
Tumor in the carpel tunnel
Older age
Placing of your wrists while using your keyboard or mouse
Continuous exposure to vibrations from using hand-tools or power-tools
playing the piano or typing
Symptoms:
Symptoms begin slowly, early symptoms occur along the nerve path because of compression of the median nerve. Your hand may asleep often and drop objects.
Early symptoms are numbness, tingling, and pain in your thumb and the first three fingers of your hand, wrist pain at night that interferes with sleep.
Symptoms in the daytime include: tingling in the fingers, pain and burning that travels up your arm, weakness in the muscles of the hand, unable to use the hand for small tasks like- picking small objects, unable to drive, unable to hold book to read, difficult in writing, unable to type on computer keyboard.
(Added: Tue Oct 26 2021 Hits: 14 Rating: 0.00 Votes: 0) Rate It
- How the dosage of Paracetamol is defined?
- It is common in Indian households to take paracetamol. Many ailments can be treated with paracetamol, including headaches, fevers, back pain, menstruation pain, and toothaches. When we're unwell, many of us take paracetamol without contacting a doctor.
In this blog from Farmson, a noted and distinct Paracetamol PH-EUR supplier in Europe will discuss the ways to take paracetamol medication. Farmson is one of India's leading paracetamol/acetaminophen manufacturers, and they strongly advise using the recommendations below.
- During Pregnancy:
If you're pregnant or breastfeeding, talk to your doctor before taking Acetaminophen powder or a paracetamol dose. The effects of acetaminophen powder or paracetamol on a woman's reproductive system are unknown.
- Consult Physician:
It is extremely recommended that you only take paracetamol crystal, paracetamol Bp, or paracetamol tablet as instructed by your doctor. The consequences of taking paracetamol without knowing what you're doing could be disastrous. The amount of paracetamol consumed is influenced by age, gender, health, and other factors.
Farmson is a distinguished Paracetamol PH-EUR exporter in Europe.
- Lab Test:
Please inform the lab medical professionals if you are taking paracetamol and have a lab test scheduled. Depending on the type of checkup you're having, this will help them take further measures.
- Acetaminophen powder:
Paracetamol contains acetaminophen powder. In actuality, Farmson acetaminophen powder is exported all over the world. Make sure you don't have any allergies before taking acetaminophen powder for sale or paracetamol. Avoid combining acetaminophen powder medications with other acetaminophen powder medications. It's possible that the outcome will be negative. Make sure there is a smaller amount of Acetaminophen powder in the mix when giving it to babies.
Farmson is the most reputed and excellent Paracetamol PH-EUR supplier in Europe.
- Dosage:
One of the most important paracetamol dos and don'ts is to follow the doctor's recommendations. While overconsumption can be dangerous, underconsumption will not fix your health problem. It is critical to take your medication exactly as directed by your doctor in order to keep your body safe.
As one of India's leading paracetamol manufacturers, Farmson highly urges men, women, and children to carefully study the above-mentioned guidelines before using the paracetamol drug. Farmson also sells acetaminophen powder and mebendazole powder under licence.
(Added: Tue Oct 26 2021 Hits: 17 Rating: 0.00 Votes: 0) Rate It
- New Desiccant Products at Medica 2021
- This year, Baltimore Innovations will be unveiling a new range of Humidity Balancing desiccants at Medica 2021. These HUMI-BALANCE™ Sachets are ideal for applications where products need to be protected not only from moisture, but also from over-drying. Visitors to the Medica Show can learn more about these new products on Stand 1F11-3 in Hall 1. The show runs from between 15th to the 18th November in Dusseldorf, Germany and is the world’s largest trade fair for the medical sector.
At this year’s show, Baltimore’s on-stand team will include product experts: Philippe Depois and Matthew Valentine. Philippe Depois, Global Sales Director, has over 20 year’s experience in Pharmaceutical Packaging. Matthew Valentine, Managing Director at Baltimore Innovations, has similar levels of experience, serving Baltimore’s list of multi-national Pharma and Medical Device customers.
Visitors at the stand will also get to witness Baltimore’s new PRONTO-PACKER™ Desiccant Dispenser. This new high-speed unit has been developed over the past 4 years. Baltimore are so confident of its performance, that they are guaranteeing problem-free operation, backed-up by local servicing.
Other products on display at the stand include: SUPERDRYPAK™ Silica Gel Sachets and B-SURE™ Barrier Foil Pouches.
“We look forward to offering visitors solutions to the many different Moisture-Control problems that they have. With over 40 years’ of experience available at our booth, we stand a good chance of success!” says Philippe Depois, Global Sales Director at Baltimore Innovations.
Note to Editors:
Founded in 1996 and named after the US city in which industrial desiccants were first synthesized, Baltimore Innovations specialise in desiccants and moisture-proof packaging. They now service over 50 countries world-wide. Their products are supplied to the smallest SMEs as well as to some of the world’s largest companies such as; Alere, GlaxoSmithKline, and BP to name but a few.
Baltimore has its HQ and Worldwide Distribution Centre close to London’s Heathrow Airport, is a member of the Pharmaceutical Quality Group and holds several awards including an Interphex Award for its new desiccant technology in the best new or redesigned pack or device for ethical or OTC pharmaceuticals category.
(Added: Mon Oct 25 2021 Hits: 11 Rating: 0.00 Votes: 0) Rate It
- 2021 Mammography Market Global Analysis Report
- Stratistics MRC 2021 Mammography Market report is It is a standard diagnostic and screening technique that is employed all over the world.
Mammography is a medical imaging technique that employs low-dose X-rays to screen breast tissues to check the presence of a malignant tumor. It is a standard diagnostic and screening technique that is employed all over the world.
Browse complete “Mammography Market” report with TOC @ https://www.strategymrc.com/report/mammography-market
Based on the product, the digital systems segment is anticipated to expand at a rapid pace during the forecast period owing to its commercial availability and its increasing popularity among healthcare professionals. By geography, North America is going to have high growth during the forecast period which can be attributed to the presence of highly developed healthcare facilities along with the increasing health awareness among people.
Some of the key players profiled in the Mammography Market include Siemens Healthineers, Fujifilm Holdings Corporation, Koninklijke Philips NV, General Medical Merate SPA, Toshiba Medical Systems, GE Healthcare, Canon Medical Systems Corporation, Quest Diagnostics Incorporated, Mindray Medical International Limited, Metaltronica SpA , Planmed Oy, Hologic Inc, Carestream Health, Konica Minolta Inc, and IMS S.r.l.
Request a Sample of “Mammography Market” @ https://www.strategymrc.com/report/mammography-market/request-sample
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
Company Profiling
Comprehensive profiling of additional market players (up to 3)
SWOT Analysis of key players (up to 3)
Regional Segmentation
Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
For more information about this report visit https://www.strategymrc.com/report/mammography-market
Report Store: https://www.strategymrc.com/report-store
Covid-19 reports: https://www.strategymrc.com/covid-19-impact-reports
About Us:
Stratistics MRC offer a wide spectrum of research and consulting services with in-depth knowledge of different industries. Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects.
Contact Us:
Email: sales@strategymrc.com
Organization: Stratistics Market Research Consulting Pvt Ltd
Phone: +1-301-202-5929
Website: https://www.strategymrc.com
(Added: Mon Oct 25 2021 Hits: 22 Rating: 0.00 Votes: 0) Rate It
- mental health congress
- Mental Health Congress 2022 aims to discover advances in Mental Health, management and instruction in connection to wellbeing differences and a broadness of different points. We are bringing the in-person events you love right to your living room.
(Added: Sat Oct 23 2021 Hits: 22 Rating: 0.00 Votes: 0) Rate It
- Gynecology consultants clinic & surgery
- Consult Gynecologist is the medical practice dealing with the health of the female reproductive systems.They diagnose and treat issues related to the female reproductive tract. This includes the uterus, fallopian tubes, and ovaries and breasts.
Anyone with female organs may see a gynecologist. 80% of those who see one are between 15 to 45 years old. Gynecologists give reproductive and sexual health services that include pelvic exams, Pap tests, cancer screenings, and testing and treatment for vaginal infections.
They diagnose and treat reproductive system disorders such as endometriosis, infertility, ovarian cysts, and pelvic pain. They may also care for people with ovarian, cervical, and other reproductive cancers.
Some gynecologists also practice as obstetricians, who give care during pregnancy and birth. If a gynecologist has expertise in obstetrics, they’re called an OB-GYN.It’s important to have regular visits with your gynecologist to maintain your reproductive health. According to the American College of Obstetricians and Gynecologists, these visits should start between the ages of 13 and 15.
Depending on your health history and how old you are, the medical advisor team will arrange the visit to screen the problems. You can talk to the female gynecologist about reproductive health concerns like birth control. Please Visit- https://www.consultgynecologist.com/
(Added: Fri Oct 22 2021 Hits: 15 Rating: 0.00 Votes: 0) Rate It
- Can Addiction be passed on to next-generation via heredity?
- Everyone understands what addiction is, but it can be difficult to pinpoint the origins of this condition. Is it brought on by stress? Is it a genetic disorder with profound roots? Or does substance misuse appear out of nowhere? Continue reading to find out if addiction may be passed down via the family tree.
Addiction is a chronic brain disorder that requires tremendous courage and desire to overcome. Because this condition affects the brain's reward system, illicit substances such as cocaine or alcohol will hyper-activate the mind's many reward centres.
Central Florida Recovery ranks high among the top Florida rehabilitation centres.
Hereditary and genetic variables are responsible for around 50-75 per cent of the causes of substance abuse and addiction. Addictive behaviours may be more prevalent in people who have particular genes or inherited effects.
Here are some inherited and genetic factors that influence addiction:
● Addictions are more common in people who have a smaller amygdala.
● Certain genes play an important role in substance misuse. Those who lack a serotonin receptor gene, for example, are more likely to develop an addiction to alcohol or cocaine.
● Individuals who have experienced addiction disorders in their parents or grandparents are more likely to acquire addictive tendencies.
● Individuals with numerous addiction-related genes are more prone to develop drug addiction.
Central Florida Recovery is one of the most prominent rehab centres in Florida.
While there are many inherited causes for addiction, there are also several environmental elements that may lead to dependence.
Surrounding Factors affecting Addiction:
Those who are affected by tragedy or who are exposed to addiction at a young age are more prone to have substance misuse problems later in life. Growing up in a home with drug users, having a mental illness, losing a loved one, being fired from a job, and stress-related triggers are all environmental variables that could lead to addiction.
Central Florida Recovery is one of the most effective addiction treatment centres in Florida.
Finally, both environmental and inherited variables influence substance abuse diseases. Hereditary influences, on the other hand, have a higher risk of producing addiction.
Prevention of hereditary addiction:
Because hereditary factors do play a part in addiction, those who have a family member who is addicted are more prone to acquire a substance misuse problem. Even if you are susceptible to addiction, there are techniques to avoid or prevent it.
To begin, you must be aware of your addictive tendencies. If you understand the origins and symptoms of substance misuse, you will be better equipped to recognise addictive behaviours in yourself. Identify all of your potential triggers and do your best to avoid them.
Central Florida Recovery if you are searching for the best Florida addiction and recovery centre, Central Florida Recovery is the right place for you.
Other measures to avoid addiction include maintaining good mental health, practising self-care, and staying physically active.
Addiction, on the other hand, cannot always be avoided. However, if addiction develops for genetic or other causes, there are ways to halt it. Detox, which should be provided by a professional in a medical centre or rehabilitation facility, is usually the first step on the road to sobriety.
After detox, persons suffering from addiction can continue their recovery by participating in inpatient/outpatient treatment, one-on-one or family therapy, and support groups.
(Added: Fri Oct 22 2021 Hits: 24 Rating: 0.00 Votes: 0) Rate It
- 2021 Retail Clinics Market Global Analysis Report
- Stratistics MRC’s 2021 Retail Clinics Market report is retail clinics provide healthcare services across departmental stores, supermarkets, and retail stores.
Retail clinics or walk-in clinics also known as urgent care clinics are the alternative treatment sites that deliver care from a qualified provider in settings outside of the emergency department or traditional office. Retail clinics provide primary healthcare services across departmental stores, supermarkets, and retail stores. These retail clinics are gaining immense popularity as they are highly beneficial for public health, easily accessible, and also help in reducing the pressure on public healthcare services.
Browse complete “Retail Clinics Market” report with TOC @ https://www.strategymrc.com/report/retail-clinics-market
By geography, Asia Pacific is going to have high growth during the forecast period due to the rapid growing population and improving efforts to cut down the pressure on hospitals, and growing focus on outpatient care are some of the key factors for the development of Asia Pacific market.
Some of the key players profiled in the Retail Clinics Market include The Kroger Co., Walmart Inc., Walgreens co., Nextcare Holdings, Inc., MedExpress, Doctors care, Bellin Health Systems, Concentra, Inc., CVS Health’s MinuteClinic, Urgent Care MSO, Rite Aid, RediClinic LLC and U.S. HealthWorks.
Request a Sample of “Retail Clinics Market” @ https://www.strategymrc.com/report/retail-clinics-market/request-sample
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
Company Profiling
Comprehensive profiling of additional market players (up to 3)
SWOT Analysis of key players (up to 3)
Regional Segmentation
Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
For more information about this report visit https://www.strategymrc.com/report/retail-clinics-market
Report Store: https://www.strategymrc.com/report-store
Covid-19 reports: https://www.strategymrc.com/covid-19-impact-reports
About Us:
Stratistics MRC offer a wide spectrum of research and consulting services with in-depth knowledge of different industries. Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects.
Contact Us:
Email: sales@strategymrc.com
Organization: Stratistics Market Research Consulting Pvt Ltd
Phone: +1-301-202-5929
Website: https://www.strategymrc.com
(Added: Fri Oct 22 2021 Hits: 18 Rating: 0.00 Votes: 0) Rate It
- Protectimus releases Electronic Visit Verification (EVV) Solution based on TOTP hardware tokens
- Two-factor authentication provider Protectimus suggests using a Time-Based One-Time Password algorithm (TOTP) for Electronic Visit Verification (EVV). Protectimus EVV system allows the homecare service providers to use one-time codes from hardware TOTP tokens to determine the exact time and duration of visits of their employees to the clients.
All the US companies providing personal care and home healthcare services should adopt electronic visit verification by January 1, 2023. The main goal of such a move is to improve the standards of services in the homecare area:
- make sure that people receiving home care services are not neglected;
- provide the companies with an effective tool for identifying dishonest employees (some workers could fake the lists of clients they visited throughout the day before the introduction of EVV);
- ensure efficient use of the Medicaid budget.
Among the commonly used electronic visit verification methods are landlines to call from the patients' homes, tracking the employees' activity with the help of GPS trackers, and installing video cameras in the patients’ houses.
Such EVV systems serve their purpose. Yet, there are several shortcomings in using them:
- many people, who get help at home, worry about the violation of their privacy;
- the installation of additional equipment requires extra time and expenses;
- the electronic visit verification software needs to be constantly updated, and it may be cumbersome for some people.
Protectimus suggests the easiest possible approach to Electronic Visit Verification. And this approach eliminates all the disadvantages described above. It is possible to use hardware TOTP tokens as EVV devices because a time-based one-time password generation algorithm allows determining the exact time when every one-time password was generated.
Let’s have a look at the procedure of electronic visit verification with TOTP tokens.
1. A person, who receives healthcare or personal care services at home, gets a hardware TOTP token. This EVV device looks like a standard keyfob with one button and a small display. It can be easily affixed somewhere in the house if necessary.
2. When an employee providing homecare services arrives at the client’s household, they press the button on the TOTP token to get the one-time password. And then, they write the one-time password down in their notepad.
3. After the job is done, an employee uses the TOTP token to generate the one-time password again and writes it down just like the first one.
4. At the end of the day or immediately after providing the services, the employee enters the one-time codes into the electronic visit verification system.
5. The EVV system transfers the OTP codes to the Protectimus two-factor authentication service. Protectimus calculates the precise time when these one-time codes were generated and sends the results back to the Electronic Visit Verification system.
6. This way, the TOTP algorithm makes it possible to control the time and duration of visits of healthcare and home care specialists to their clients.
Protectimus offers two types of TOTP tokens for EVV: with 6-digit and 8-digit displays. Both models of EVV devices are protected from moisture and dust, serve for more than five years, and have a 12-months warranty.
The server part of the Protectimus EVV solution that processes the one-time codes is available as a cloud service or an on-premise platform. It can be integrated with any EVV system using API.
Learn more about the Protectimus EVV solution and book a demo at the official website: https://www.protectimus.com/evv/
(Added: Thu Oct 21 2021 Hits: 11 Rating: 0.00 Votes: 0) Rate It
- Toxic Lead - Still Here, Still Harming
- Press Release
(EMBARGO: 00.01 Sunday 24th October 2021)
Toxic Lead - Still Here, Still Harming
It is the WHO International Lead Poisoning Prevention Week from 24th to 30th October. Unicef estimate that 186,117 to 281,542 UK children have dangerous concentrations of lead in their blood. This could be costing the country 0.31% of GDP or £6bn per year.
The UK stopped using lead in paint, pipes and petrol decades ago, but the toxic legacy remains. 82% of homes were built before lead paint was banned, an estimated 9 million homes still have lead pipes, lead from petrol and paint is still found in soil; and lead exposure can come from many continuing sources.
President Biden said that lead pipes are “a clear and present danger to our children” and proposed spending $45bn to fix the problem. The US EPA says lead poisoning is the number one environmental health threat to children ages six and younger. The UK’s use of lead has been similar to the USA.
Lead toxicity can cause a wide range of health problems including:
• Reproductive – miscarriage, pre-term birth, low birth weight, delayed puberty
• Neurological - IQ loss, decreased hearing
• Psychological - problem behaviours, ADHD, depression, anxiety, panic
• Cardiovascular – heart attack, stroke, increased blood pressure
• Renal – reduced kidney function
The LEAPP Alliance is a group of academics, service providers, advocates and parents who are campaigning to achieve improvements in the UK response to continued lead exposure. Our current objectives include achieving:
1. Screening of children for elevated blood lead concentrations (EBLC)
2. Research into the prevalence of EBLCs in children and pregnancy
3. Training and accreditation of employers and workers
4. Policies to cut lead exposure and toxicity including inclusion in the following:
a. “Giving Every Child The Best Start In Life” programme
b. Healthy Homes and Buildings White Paper
c. NHS Long-term Plan
5. Ensuring the UK matches the new, lower EU limits on lead in food
6. Provision of more information on the dangers of lead exposure to the following:
a. Health care providers, particularly GPs
b. Housing leaders – tenants and housing associations, professional bodies
c. Tradesmen and DIYers
There are many low-cost interventions that can help reduce lead exposure, which is a “health problem with a housing solution”, that impacts disadvantaged children the most.
Lead Exposure and Poisoning Prevention Alliance (LEAPP)
'ENDS'
Contact information
Tim Pye, info@leappalliance.org.uk, 07768 337619
https://leappalliance.org.uk/
Notes for editors
This issue is potentially a huge story for the UK - as it has become in the USA. Some say it is the new asbestos. A great deal has been written about lead poisoning in children and there is extensive research confirming the problem and explaining the solutions. However, UK government agencies’ responses remain one of yes, but it is not our job. The UK has never set a lead reduction target until it has been met. Please consider writing, or commissioning, an article to help fix this problem. Perhaps, like the people of Alameda County, California, “Together we can conquer lead poisoning”.
Our “Manifesto for a Lead-Safe UK” explains the issue in more detail with full references to scientific papers and government sources.
UK information can be found at:
• LEAPP Alliance
• Lead Containing Materials Association
• Lead In The Water
• Lead Safe World UK
Other useful sources include:
Web Sites
• US National Lead Poisoning Prevention Week 2021
• United States, Centres for Disease Control, Lead
• United States, Environment Protection Agency, Lead
• World Health Organization, Lead Poisoning and Health
• American Academy of Pediatrics, Lead Exposure and Lead Poisoning
• The LEAD Group
Reports
• Unicef, The Toxic Truth
• United States, US National Toxicological Programme, Monograph, Health Effects of Low-Level
• United States, Environment Protection Agency, Integrated Science Assessment
• for Lead
• SW Londoner, ‘I was constantly paranoid’ the danger of lead paint in UK homes
Videos
• Royal College of Paediatrics and Child Health, Lead Toxicity in Children - a continuing problem
• Oneida County Health Department, New York, "Lead Poisoning: The Perfect Predator"
• Alameda County, California, “Together We Can Conquer Lead Poisoning”
• TVNZ, “How much does NZ really know about the risks of lead?”
• Unicef, Why lead poisoning is a danger to your child's health – “Put lead to bed”
(Added: Thu Oct 21 2021 Hits: 13 Rating: 0.00 Votes: 0) Rate It
- Toxic Lead - Still Here, Still Harming
- Press Release
(EMBARGO: 00.01 Sunday 24th October 2021)
Toxic Lead - Still Here, Still Harming
It is the WHO International Lead Poisoning Prevention Week from 24th to 30th October. Unicef estimate that 186,117 to 281,542 UK children have dangerous concentrations of lead in their blood. This could be costing the country 0.31% of GDP or £6bn per year.
The UK stopped using lead in paint, pipes and petrol decades ago, but the toxic legacy remains. 82% of homes were built before lead paint was banned, an estimated 9 million homes still have lead pipes, lead from petrol and paint is still found in soil; and lead exposure can come from many continuing sources.
President Biden said that lead pipes are “a clear and present danger to our children” and proposed spending $45bn to fix the problem. The US EPA says lead poisoning is the number one environmental health threat to children ages six and younger. The UK’s use of lead has been similar to the USA.
Lead toxicity can cause a wide range of health problems including:
• Reproductive – miscarriage, pre-term birth, low birth weight, delayed puberty
• Neurological - IQ loss, decreased hearing
• Psychological - problem behaviours, ADHD, depression, anxiety, panic
• Cardiovascular – heart attack, stroke, increased blood pressure
• Renal – reduced kidney function
The LEAPP Alliance is a group of academics, service providers, advocates and parents who are campaigning to achieve improvements in the UK response to continued lead exposure. Our current objectives include achieving:
1. Screening of children for elevated blood lead concentrations (EBLC)
2. Research into the prevalence of EBLCs in children and pregnancy
3. Training and accreditation of employers and workers
4. Policies to cut lead exposure and toxicity including inclusion in the following:
a. “Giving Every Child The Best Start In Life” programme
b. Healthy Homes and Buildings White Paper
c. NHS Long-term Plan
5. Ensuring the UK matches the new, lower EU limits on lead in food
6. Provision of more information on the dangers of lead exposure to the following:
a. Health care providers, particularly GPs
b. Housing leaders – tenants and housing associations, professional bodies
c. Tradesmen and DIYers
There are many low-cost interventions that can help reduce lead exposure, which is a “health problem with a housing solution”, that impacts disadvantaged children the most.
Lead Exposure and Poisoning Prevention Alliance (LEAPP)
'ENDS'
Contact information
Tim Pye, info@leappalliance.org.uk, 07768 337619
https://leappalliance.org.uk/
Notes for editors
This issue is potentially a huge story for the UK - as it has become in the USA. Some say it is the new asbestos. A great deal has been written about lead poisoning in children and there is extensive research confirming the problem and explaining the solutions. However, UK government agencies’ responses remain one of yes, but it is not our job. The UK has never set a lead reduction target until it has been met. Please consider writing, or commissioning, an article to help fix this problem. Perhaps, like the people of Alameda County, California, “Together we can conquer lead poisoning”.
Our “Manifesto for a Lead-Safe UK” explains the issue in more detail with full references to scientific papers and government sources.
UK information can be found at:
• LEAPP Alliance
• Lead Containing Materials Association
• Lead In The Water
• Lead Safe World UK
Other useful sources include:
Web Sites
• US National Lead Poisoning Prevention Week 2021
• United States, Centres for Disease Control, Lead
• United States, Environment Protection Agency, Lead
• World Health Organization, Lead Poisoning and Health
• American Academy of Pediatrics, Lead Exposure and Lead Poisoning
• The LEAD Group
Reports
• Unicef, The Toxic Truth
• United States, US National Toxicological Programme, Monograph, Health Effects of Low-Level
• United States, Environment Protection Agency, Integrated Science Assessment
• for Lead
• SW Londoner, ‘I was constantly paranoid’ the danger of lead paint in UK homes
Videos
• Royal College of Paediatrics and Child Health, Lead Toxicity in Children - a continuing problem
• Oneida County Health Department, New York, "Lead Poisoning: The Perfect Predator"
• Alameda County, California, “Together We Can Conquer Lead Poisoning”
• TVNZ, “How much does NZ really know about the risks of lead?”
• Unicef, Why lead poisoning is a danger to your child's health – “Put lead to bed”
(Added: Thu Oct 21 2021 Hits: 16 Rating: 0.00 Votes: 0) Rate It
- The biopharmaceutical contract fabricating market is projected
- Roots Analysis has done a detailed study on Biopharma Contract Manufacturing Market (3rd Edition), 2019-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
To order this 750+ page report, which features 200+ figures and 250+ tables, please visit Biopharma Contract Manufacturing Market (3rd Edition), 2019-2030
Key Market Insights
Over 235 companies worldwide claim to offer contract manufacturing services for various types of biopharmaceutical drug / therapy products.
The market landscape is highly fragmented featuring the presence of both established players and new entrants; majority of biopharmaceutical CMOs are based in the developed geographies.
Case study: CMOs focusing on niche biologic markets, primarily novel product candidates for which in-house biomanufacturing expertise is low, are likely to experience significant growth in the coming years.
The installed global contract manufacturing capacity, spread across various geographies, is currently estimated to be over 4.5 million liters.
The demand for contract manufacturing services is expected to rise across different therapeutic areas; closer inspection of available capacity and expected utilization trend are required to optimize supply parameters.
With over 450 deals inked in the past six years, there has been a surge in the partnership activity; majority of the collaborations have been signed for the development and manufacturing of cell therapies and antibodies.
In order to cater the increasing demand for biologics, stake holders are actively expanding their existing capabilities; this is evident from the various acquisitions that have recently been reported.
We expect the developers to continue to outsource their manufacturing operations in the short to mid-term, resulting in an annualized growth rate of more than 8%.
In the long term, the projected opportunity is anticipated to be well distributed across various types of expression systems used for biomanufacturing, scale of operation and size of contract service providers
For more information, please visit https://rootsanalysis.com/reports/view_document/biopharma-contract-manufacturing-market-3rd-edition-2019-2030/250.html
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
ben.johnson@rootsanalysis.com
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
(Added: Thu Oct 21 2021 Hits: 19 Rating: 0.00 Votes: 0) Rate It
- The prefilled needles market is projected to develop at an annualized pace of ~5%, till 2030
- Roots Analysis has done a detailed study on Prefilled Syringes, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
To order this 800+ page report, which features 800+ figures and 150+ tables, please visit https://www.rootsanalysis.com/reports/view_document/prefilled-syringes-market/284.html
Key Market Insights
Presently, around 80 types of prefilled syringes are available in the market, and several companies claim to be engaged in the manufacturing of both glass and plastic variants of such versatile drug delivery solutions
Over 140 drugs and vaccines have either been marketed or have undergone clinical investigation (since 2013) for delivery via prefilled syringes for the treatment of a variety of disease indications
In order to gain a competitive edge in the market, prefilled syringe manufacturers are actively engaged in developing patient friendly products, with improved safety features and solutions
The market is also characterized by the presence of many contract service providers, spread across the world, offering fill / finish services in prefilled syringes
Several big pharma companies are actively engaged in strengthening their pipeline of injectable drugs across various therapeutic areas
An evaluation of 280+ marketed and pipeline products revealed that a variety of drugs / product candidates are likely to be considered for administration via prefilled syringes in the near future, paving way for new partnerships
The current market opportunity is well distributed across different therapeutic areas, molecule types and geographical regions; the market is likely to grow at a steady pace over the coming years
Glass, single chamber prefilled syringes dominate the current market; however, the demand for plastic devices is anticipated to witness a relatively higher growth in the foreseen future
For more information, please visit https://www.rootsanalysis.com/reports/view_document/prefilled-syringes-market/284.html
Table of Contents
1. PREFACE
1.1. Chapter Overview
1.2. Scope of the Report
1.3. Research Methodology
1.4. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION TO PREFILLED SYRINGES
3.1. Chapter Overview
3.2. History of Prefilled Syringes
3.3. Benefits of Prefilled Syringes Over Traditional Injectable Devices
3.3.1. Benefits for Healthcare Professionals and End Users
3.3.2. Benefits to Manufacturers
3.3.3. Shift from Existing Dosage Forms to Prefilled Syringes
3.4. Prefilled Syringe Components
3.5. Classification of Prefilled Syringes
3.5.1. Classification by Barrel Fabrication Material
3.5.1.1. Glass
3.5.1.1.1. Limitations of Glass Barrel Prefilled Syringes
3.5.1.1.2. Addressing the Limitations of Glass Barrel Prefilled Syringes
3.5.1.2. Plastic
3.5.1.2.1. Limitations of Plastic Barrel Prefilled Syringes
3.5.1.2.2. Addressing the Limitations of Plastic Barrel Prefilled Syringes
3.5.1.2.3. Factors Likely to Drive the Use of Plastic Barrel Prefilled Syringes
3.5.2. Classification by Number of Chambers in the Barrel
3.5.3. Classification by Type of Needle System
3.5.4. Classification by Type of Packaging
3.6. Critical Attributes of Prefilled Syringe Design
3.7. Manufacturing Prefilled Syringes
3.7.1. Production of Barrels
3.7.1.1. Glass Barrel Prefilled Syringes
3.7.1.2. Plastic Barrel Prefilled Syringes
3.7.2. Production of Syringes
3.7.3. Barrel Siliconization
3.7.4. Syringe Sterilization
3.7.5. Validation of Sterilization
3.7.6. Syringe Filling
3.7.7. Syringe Testing
3.8. Future of Prefilled Syringes
4 PREFILLED SYRINGES: MARKET OVERVIEW
4.1. Chapter Overview
4.2. Prefilled Syringes: List of Available / Under Development Devices
4.2.1. Analysis by Type of Barrel Fabrication Material
4.2.2. Analysis by Number of Barrel Chambers
4.2.3. Analysis by Type of Needle System
4.2.4. Analysis by Device Capacity
4.3. Prefilled Syringes: List of Developers
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Geographical Location of Headquarters
4.3.4. Analysis by Geographical Location of Manufacturing Facilities
4.4. Technological Developments in Prefilled Syringes
5 PRODUCT COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Methodology
5.3. Assumptions and Key Parameters
5.4. Product Competitiveness Analysis: Prefilled Syringe Systems
5.4.1. Glass Barrel Prefilled Syringes
5.4.2. Plastic Barrel Prefilled Syringes
6 MANUFACTURERS OF PREFILLED SYRINGES
6.1. Chapter Overview
6.2. Key Prefilled Syringe Manufacturers Based in North America
6.2.1. Becton Dickinson
6.2.1.1. Company Overview
6.2.1.2. Financial Performance
6.2.1.3. Prefilled Technology Solutions
6.2.1.4. Glass Barrel Prefilled Systems
6.2.1.4.1. BD Hypak Prefilled Syringe
6.2.1.4.2. BD Neopak Prefilled Syringe
6.2.1.4.3. BD Hylok Prefilled Syringe
6.2.1.5. Plastic Barrel Prefilled Systems
6.2.1.5.1. BD Sterifill Syringe Systems
6.2.1.6. Other Prefilled Delivery Systems
6.2.1.6.1. BD Uniject
6.2.1.7. Recent Developments
6.2.1.8. Future Outlook
6.2.2. West Pharmaceutical
6.2.2.1. Company Overview
6.2.2.2. Financial Performance
6.2.2.3. Prefilled Technology Solutions
6.2.2.4. Plastic Barrel Prefilled Systems
6.2.2.4.1. Daikyo Crystal Zenith Polymer RTU Prefilled Syringe
6.2.2.5. Drug Reconstitution Systems
6.2.2.6. Recent Developments
6.2.2.7. Future Outlook
6.3. Key Prefilled Syringe Manufacturers Based in Europe
6.3.1. Gerresheimer
6.3.1.1. Company Overview
6.3.1.2. Financial Performance
6.3.1.3. Prefilled Technology Solutions
6.3.1.4. Glass Barrel Prefilled Systems
6.3.1.4.1. Gx Glass Syringes
6.3.1.5. Plastic Barrel Prefilled Systems
6.3.1.5.1. ClearJect Prefilled syringes
6.3.1.5.2. Gx RTF Clearject Needle Syringe
6.3.1.6. Safety Syringes
6.3.1.6.1. Gx InnoSafe Safety Syringes
6.3.1.7. Self-Injection Devices
6.3.1.8. Recent Developments
6.3.1.9. Future Outlook
6.3.2. Ompi
6.3.2.1. Company Overview
6.3.2.2. Financial Performance
6.3.2.3. Glass Barrel Prefilled Systems
6.3.2.3.1. EZ-Fill Syringes
6.3.2.3.1.1. EZ-fill Fina
6.3.2.3.1.2. EZ-fill Nexa
6.3.2.3.1.3. EZ-fill Alba
6.3.2.4. Recent Developments
6.3.2.5. Future Outlook
6.3.3. Schott
6.3.3.1. Company Overview
6.3.3.2. Financial Performance
6.3.3.3. Glass Barrel Prefilled Syringes
6.3.3.3.1. syriQ Glass Syringes
6.3.3.4. Plastic Barrel Prefilled Syringes
6.3.3.4.1. TopPac Polymer Syringes
6.3.3.5. Recent Developments
6.3.3.6. Future Outlook
6.4. Key Prefilled Syringe Manufacturers in Asia
6.4.1. Nipro (Acquired MGlas)
6.4.1.1. Company Overview
6.4.1.2. Financial Performance
6.4.1.3. Glass Barrel Prefilled Systems
6.4.1.4. Recent Developments
6.4.1.5. Future Outlook
6.4.2. WEGO Prefills Pharmaceutical Packaging
6.4.2.1. Company Overview
6.4.2.2. Financial Performance
6.4.2.3. WeGo Glass Prefilled Syringe
6.4.2.4. Weigao Prefilled Flush Syringes
6.4.2.5. Future Outlook
6.4.3. Taisei Kako
6.4.3.1. Company Overview
6.4.3.2. Glass Barrel Prefilled Systems
6.4.3.2.1. VF-Syringe
6.4.3.2.1. SIN-Syringe
6.4.3.3. Plastic Barrel Prefilled System
6.4.3.3.1. ClearJect Syringes
6.4.3.3.2. FULJECT Passive Type Syringe
6.4.3.3.3. Ajex Needleless Injection System
6.4.3.4. Future Outlook
6.4.4. Terumo
6.4.4.1. Company Overview
6.4.4.2. Financial Performance
6.4.4.3. Plastic Barrel Prefilled Syringe
6.4.4.4. Safety Devices: Add-On Devices
6.4.4.5. Recent Developments
6.4.4.6. Future Outlook
6.5. Other Manufacturers
6.5.1. Aguettant
6.5.1.1. Company Overview
6.5.1.2. Prefilled Syringe Portfolio
6.5.1.2.1. Aguettant Prefilled Syringe
6.5.1.3. Recent Developments
6.5.2. Arte
6.5.2.1. Company Overview
6.5.2.2. Prefilled Syringe Portfolio
6.5.2.2.1. Dual Chamber Prefillable Syringe
6.5.2.2.2. Single Chamber Prefillable Syringe
6.5.3. J.O. Pharma (Subsidiary of Otsuka Holdings)
6.5.3.1. Company Overview
6.5.3.2. Prefilled Syringe Portfolio
6.5.4. Pfizer Injectables
6.5.4.1. Company Overview
6.5.4.2. Prefilled Syringe Portfolio
6.5.4.2.1. ABBOJECT Syringe
6.5.4.2.2. Emergency Syringes
6.5.4.2.3. iSecure Syringe System
6.5.5. Shandong Pharmaceutical Glass
6.5.5.1. Company Overview
6.5.5.2. Prefilled Syringe Portfolio
6.5.6. Shandong Zibo Minkang Pharmaceutical packing
6.5.6.1. Company Overview
6.5.6.2. Prefilled Syringe Portfolio
6.5.7. Vetter Pharma
6.5.7.1. Company Overview
6.5.7.2. Prefilled Syringe Portfolio
6.5.7.2.1. Lyo-Ject Glass Prefilled Syringe
6.5.7.2.2. Vetter-Ject Safety Device
6.5.7.2.3. V-OVS Safety Device
6.5.7.3. Recent Developments
7 NEEDLESTICK INJURIES
7.1. Chapter Overview
7.2. Incidence and Associated Financial Burden
7.3. Government Legislations for Prevention of Needlestick Injuries
7.4. Safety Mechanisms Used in Modern Prefilled Syringes
7.4.1. Safety Systems: Add-On Safety Device Manufacturers
7.4.1.1. Becton Dickinson
7.4.1.2. Catalent
7.4.1.3. Terumo
7.4.1.4. Tip-Top
7.4.1.5. West Pharmaceutical
7.4.2. Safety Systems: Integrated Safety Device Manufacturers
7.4.2.1. Gerresheimer
7.4.2.2. Injecto
7.4.2.3. MedicalChain International
7.4.2.4. OMPI
7.4.2.5. Owen Mumford
7.4.2.6. SHL Group
7.4.2.7. Taisei Kako
8 REGULATORY LANDSCAPE FOR PREFILLED SYRINGES
8.1. Chapter Overview
8.2. Regulatory Approval of Combination Products in the US
8.2.1. Overview
8.2.2. Historical Background
8.2.3. Regulatory Bodies and their Role in Product Approval
8.2.4. Regulatory Approval for Prefilled Syringes
8.3. Regulatory Approval of Combination Products in Europe
8.3.1. Overview
8.3.2. Regulatory Bodies and their Role in Product Approval
8.3.3. Regulatory Approval for Prefilled Syringes
8.4. Regulatory Approval of Combination Products in Canada
8.4.1. Overview
8.4.2. Regulatory Bodies and their Role in Product Approval
8.4.3. Regulatory Approval for Prefilled Syringes
8.5. Regulatory Approval of Combination Products in Brazil
8.5.1. Overview
8.5.2. Regulatory Bodies and their Role in Product Approval
8.5.3. Regulatory Approval for Prefilled Syringes
8.6. Regulatory Approval of Combination Products in Mexico
8.6.1. Overview
8.6.2. Regulatory Bodies and their Role in Product Approval
8.6.3. Regulatory Approval for Prefilled Syringes
8.7. Regulatory Approval of Combination Products in Argentina
8.7.1. Overview
8.7.2. Regulatory Bodies and their Role in Product Approval
8.7.3. Regulatory Approval for Prefilled Syringes
8.8. Regulatory Approval of Combination Products in Australia
8.8.1. Overview
8.8.2. Regulatory Bodies and their Role in Product Approval
8.8.3. Regulatory Approval for Prefilled Syringes
8.9. Regulatory Approval of Combination Products in Japan
8.9.1. Overview
8.9.2. Regulatory Bodies and their Role in Product Approval
8.9.3. Regulatory Approval for Prefilled syringes
8.10. Regulatory Approval of Combination Products in China
8.10.1. Overview
8.10.2. Regulatory Bodies and their Role in Product Approval
8.10.3. Regulatory Approval for Prefilled syringes
8.11. Regulatory Approval of Combination Products in India
8.11.1. Overview
8.11.2. Regulatory Bodies and their Role in Product Approval
8.11.3. Regulatory Approval for Prefilled Syringes
8.12. Regulatory Approval of Combination Products in South Korea
8.12.1. Overview
8.12.2. Regulatory Bodies and their Role in Product Approval
8.12.3. Regulatory Approval for Prefilled Syringes
8.13. Regulatory Approval of Combination Products in Saudi Arabia
8.13.1. Overview
8.13.2. Regulatory Bodies and their Role in Product Approval
8.13.3. Regulatory Approval for Prefilled Syringes
8.14. Regulatory Approval of Combination Products in United Arab Emirates
8.14.1. Overview
8.14.2. Regulatory Bodies and their Role in Product Approval
8.14.3. Regulatory Approval for Prefilled Syringes
9 PREFILLED SYRINGE COMBINATION PRODUCTS: MARKET OVERVIEW
9.1. Chapter Overview
9.2. Prefilled Syringe Combination Products: List of Approved Drugs, 2013-2019
9.2.1. Analysis by Type of Drug Molecule
9.2.2. Analysis by Approval Year
9.2.3. Analysis by Route of Administration
9.2.4. Analysis by Target Therapeutic Area
9.2.5. Prefilled Syringe Combination Products: Additional Information
9.2.5.1. Analysis by Dose Strength
9.2.5.2. Analysis by Other Approved Dosage Forms
9.3. Prefilled Syringe Combination Products: List of Clinical Stage Drugs, 2013-2019
9.3.1. Analysis by Type of Drug Molecule
9.3.2. Analysis by Phase of Development
9.3.3. Analysis by Route of Administration
9.3.4. Analysis by Target Therapeutic Area
9.4. Prefilled Syringe Combination Products: List of Developers
9.4.1. Analysis by Year of Establishment
9.4.2. Analysis by Company Size
9.4.3. Analysis by Geographical Location of Headquarters
9.5. Leading Drugs in Prefilled Syringes
9.6. Other Drugs Available in Prefilled Syringes
9.7. Popular Drugs in Prefilled Syringes: Case Studies
9.7.1. HUMIRA® (Adalimumab), AbbVie / Eisai
9.7.1.1. Target Indications and Available Dosage Forms
9.7.1.2. Shift from Vials to Syringes
9.7.2. Enbrel® (Etanercept), Amgen / Pfizer / Takeda
9.7.2.1. Target Indications and Available Dosage Forms
9.7.2.2. Shift from Vials to Syringes
10 KEY THERAPEUTIC AREAS
10.1. Chapter Overview
10.1.1. Autoimmune Disorders
10.1.1.1. Approved Injectables
10.1.1.2. Biosimilars
10.1.2. Infectious Diseases
10.1.2.1. Antiviral Drugs
10.1.2.1.1. Approved Injectables
10.1.2.1.2. Biosimilars
10.1.2.2. Vaccines
10.1.2.2.1. Approved Injectables
10.1.3. Neurological Disorders
10.1.3.1. Approved Injectables
10.1.3.2. Biosimilars
10.1.4. Metabolic Disorders
10.1.4.1. Approved Injectables
10.1.4.2. Biosimilars
11 PREFILLED SYRINGES: LIKELY DRUG CANDIDATES AND PARTNER ANALYSIS
11.1. Chapter Overview
11.2. Likely Drug Candidates
11.2.1. Methodology and Key Parameters
11.3. Marketed Drug Candidates
11.3.1. Most Likely Candidates for Delivery via Prefilled Syringes
11.3.2. Likely Candidates for Delivery via Prefilled Syringes
11.3.3. Less Likely Candidates for Delivery via Prefilled Syringes
11.3.4. Least Likely Candidates for Delivery via Prefilled Syringes
11.4. Clinical Drug Candidates
11.4.1. Most Likely Candidates for Delivery via Prefilled Syringes
11.4.2. Likely Candidates for Delivery via Prefilled Syringes
11.4.3. Less Likely Candidates for Delivery via Prefilled Syringes
11.4.4. Least Likely Candidates for Delivery via Prefilled Syringes
11.5. Potential Strategic Partners
11.5.1. Methodology and Key Parameters
11.5.2. Opportunities in North America
11.5.2.1. Most Likely Partners for Prefilled Syringes Combination Product Development
11.5.2. 2. Likely Partners for Prefilled Syringes Combination Product Development
11.5.2.3. Less Likely Partners for Prefilled Syringes Combination Product Development
11.5.2.4. Least Likely Partners for Prefilled Syringes Combination Product Development
11.5.3. Opportunities in Europe
11.5.3.1. Most Likely Partners for Prefilled Syringes Combination Product Development
11.5.3.2. Likely Partners for Prefilled Syringes Combination Product Development
11.5.3.3. Less Likely Partners for Prefilled Syringes Combination Product Development
11.5.3.4. Least Likely Partners for Prefilled Syringes Combination Product Development
11.5.4. Opportunities in Asia-Pacific and Rest of the World
11.5.4.1. Most Likely Partners for Prefilled Syringes Combination Product Development
11.5.4.2. Likely Partners for Prefilled Syringes Combination Product Development
11.5.4.3. Less Likely Partners for Prefilled Syringes Combination Product Development
11.5.4.4. Least Likely Partners for Prefilled Syringes Combination Product Development
12 BIG PHARMA INITIATIVES: PREFILLED SYRINGE COMBINATION PRODUCTS AND LIKELY CANDIDATES
12.1. Chapter Overview
12.2. Methodology
12.3. Top Pharmaceutical Companies
12.3.1. Analysis by Therapeutic Area
12.3.1.1. Autoimmune Disorders
12.3.1.2. Infectious Diseases
12.3.1.3. Oncological Disorders
12.3.1.4. Metabolic Disorders
12.3.1.5. Neurological Disorders
12.3.1.6. Inflammatory Disorders
12.3.1.7. Orthopedic Disorders
12.3.1.8. Others
12.3.2. Analysis by Type of Molecule
12.3.2.1. Antibodies
12.3.2.2. Vaccines
12.3.2.3. Proteins
12.3.2.4. Others
13 SPECIALTY PREFILLED SYRINGES
13.1. Chapter Overview
13.2. Prefilled Flush Syringes
13.2.1. Overview
13.2.2. Prefilled Flush Syringes Available in the Market
13.2.3. Advantages of Prefilled Flush Syringes
13.3. Prefilled Diluent Syringes
13.3.1. Overview
13.3.2. Lyophilized Drugs Available in Prefilled Diluent Syringes
13.3.3. Advantages of Prefilled Diluent Syringes
13.4. Contrast Agent Prefilled Syringes
13.4.1. Overview
13.4.2. Contrast Agents Available in Prefilled Syringes
13.4.3. Advantages of Contrast Agent Prefilled Syringes
14 RECENT DEVELOPMENTS AND APPLICATIONS OF PREFILLED SYRINGES
14.1. Chapter Overview
14.2. Prefilled Syringes For Lyophilized Drugs
14.2.1. Prefilled Diluent Syringes
14.2.2. Prefilled Dual / Multi-Chamber Prefilled Syringes
14.2.2.1. Lyophilized Drugs Available in Dual / Multi-Chamber Prefilled Syringes
14.2.2.2. Prefilled Dual-Chambered Prefilled Pen Injectors for Lyophilized Drugs
14.3. Prefilled Syringes for Ophthalmic Delivery
14.4. Prefilled Syringes for Dermal Fillers
14.5. Multilayer Plastic Prefilled Syringes with Oxygen Barrier
14.6. Prefilled Syringes with Low Particle Formation Risk
14.7. Lubrication Technology for Prefilled Syringes
14.8. Advances in Terminal Sterilization of Prefilled Syringes
14.8.1. Noxilizer’s Nitrogen Dioxide Sterilization Technology
14.9. Prefilled Syringe Usage Aids for patients and Healthcare Providers
15 MARKET SIZING AND OPPORTUNITY ANALYSIS
15.1. Chapter Overview
15.2. Scope and Methodology
15.3. Global Prefilled Syringes Market, 2020-2030
15.3.1. Prefilled Syringes Market: Distribution by Therapeutic Area
15.3.1.1. Prefilled Syringes Market: Autoimmune Disorders
15.3.1.2. Prefilled Syringes Market: Infectious Diseases
15.3.1.3. Prefilled Syringes Market: Neurological Disorders
15.3.1.4. Prefilled Syringes Market: Blood Disorders
15.3.1.5. Prefilled Syringes Market: Oncological Disorders
15.3.1.6. Prefilled Syringes Market: Psychiatric Diseases
15.3.1.7. Prefilled Syringes Market: Respiratory Disorders
15.3.1.8. Prefilled Syringes Market: Cardiovascular Disorders
15.3.1.9. Prefilled Syringes Market: Metabolic Disorders
15.3.1.10. Prefilled Syringes Market: Ophthalmic Disorder
15.3.1.11. Prefilled Syringes Market: Orthopedic Disorders
15.3.1.12. Prefilled Syringes Market: Other Diseases
15.3.2. Prefilled Syringes Market: Distribution by Type of Syringe Barrel Material
15.3.2.1. Prefilled Syringes Market: Glass Barrel Prefilled Syringes
15.3.2.2. Prefilled Syringes Market: Plastic Barrel Prefilled Syringes
15.3.3. Prefilled Syringes Market: Distribution by Type of Chamber System
15.3.3.1. Prefilled Syringes Market: Single Chamber Prefilled Syringes
15.3.3.2. Prefilled Syringes Market: Dual Chamber Prefilled Syringes
15.3.4. Prefilled Syringes Market: Distribution by Type of Drug Molecule
15.3.4.1. Prefilled Syringes Market: Antibodies
15.3.4.2. Prefilled Syringes Market: Proteins
15.3.4.3. Prefilled Syringes Market: Peptides
15.3.4.4. Prefilled Syringes Market: Small Molecules
15.3.4.5. Prefilled Syringes Market: Vaccines
15.3.5. Prefilled Syringes Market: Distribution by Geography
15.3.5.1. Prefilled Syringes Market: North America
15.3.5.2. Prefilled Syringes Market: Europe
15.3.5.3. Prefilled Syringes Market: Asia Pacific
15.3.5.4. Prefilled Syringes Market: Latin America
15.3.5.5. Prefilled Syringes Market: Middle East and Africa
15.3.6. Prefilled Syringes Market: Distribution by Specialty Syringes
15.3.7. Prefilled Syringes Market for Autoimmune Disorders
15.3.7.1. Distribution by Syringe Barrel Material
15.3.7.1.1. Glass Barrel Prefilled Syringes
15.3.7.1.2. Plastic Barrel Prefilled Syringes
15.3.7.2. Distribution by Type of Chamber System
15.3.7.2.1. Single Chamber Prefilled Syringes
15.3.7.2.2. Dual Chamber Prefilled Syringes
15.3.7.3. Distribution by Type of Drug Molecule
15.3.7.3.1. Antibodies
15.3.7.3.2. Proteins
15.3.7.3.3. Small Molecules
15.3.7.4. Distribution by Geography
15.3.7.4.1. North America
15.3.7.4.2. Europe
15.3.7.4.3. Asia Pacific
15.3.7.4.4. Latin America
15.3.7.4.5. Middle East and Africa
15.3.8. Prefilled Syringes Market For Infectious Disorders
15.3.8.1. Distribution by Type of Syringe Barrel Material
15.3.8.1.1. Glass Barrel Prefilled Syringes
15.3.8.1.2. Plastic Barrel Prefilled Syringes
15.3.8.2. Distribution by Type of Chamber System
15.3.8.2.1. Single Chamber Prefilled Syringes
15.3.8.2.2. Dual Chamber Prefilled Syringes
15.3.8.3. Distribution by Type of Drug Molecule
15.3.8.3.1. Vaccines
15.3.8.4. Distribution by Geography
15.3.8.4.1. North America
15.3.8.4.2. Europe
15.3.8.4.3. Asia Pacific
15.3.8.4.4. Latin America
15.3.8.4.5. Middle East and Africa
15.3.9. Prefilled Syringes Market For Neurological Disorders
15.3.9.1. Distribution by Type of Syringe Barrel Material
15.3.9.1.1. Glass Barrel Prefilled Syringes
15.3.9.1.2. Plastic Barrel Prefilled Syringes
15.3.9.2. Distribution by Type of Chamber System
15.3.9.2.1. Single Chamber Prefilled Syringes
15.3.9.2.2. Dual Chamber Prefilled Syringes
15.3.9.3. Distribution by Type of Drug Molecule
15.3.9.3.1. Antibodies
15.3.9.3.2. Proteins
15.3.9.3.3. Peptides
15.3.9.4. Distribution by Geography
15.3.9.4.1. North America
15.3.9.4.2. Europe
15.3.9.4.3. Asia Pacific
15.3.9.4.4. Latin America
15.3.9.4.5. Middle East and Africa
15.3.10. Prefilled Syringes Market For Blood Disorders
15.3.10.1. Distribution by Type of Syringe Barrel Material
15.3.10.1.1. Glass Barrel Prefilled Syringes
15.3.10.1.2. Plastic Barrel Prefilled Syringes
15.3.10.2. Distribution by Type of Chamber System
15.3.10.2.1. Single Chamber Prefilled Syringes
15.3.10.2.2. Dual Chamber Prefilled Syringes
15.3.10.3. Distribution by Type of Drug Molecule
15.3.10.3.1. Proteins
15.3.10.3.2. Small Molecules
15.3.10.4. Distribution by Geography
15.3.10.4.1. North America
15.3.10.4.2. Europe
15.3.10.4.3. Asia Pacific
15.3.10.4.4. Latin America
15.3.10.4.5. Middle East and Africa
15.3.11. Prefilled Syringes Market For Oncological Disorders
15.3.11.1. Distribution by Type of Syringe Barrel Material
15.3.11.1.1. Glass Barrel Prefilled Syringes
15.3.11.1.2. Plastic Barrel Prefilled Syringes
15.3.11.2. Distribution by Type of Chamber System
15.3.11.2.1. Single Chamber Prefilled Syringes
15.3.11.2.2. Dual Chamber Prefilled Syringes
15.3.11.3. Distribution by Type of Drug Molecule
15.3.11.3.1. Antibodies
15.3.11.3.2. Proteins
15.3.11.3.3. Peptides
15.3.11.3.4. Small Molecules
15.3.11.3.5. Vaccines
15.3.11.4. Distribution by Geography
15.3.11.4.1. North America
15.3.11.4.2. Europe
15.3.11.4.3. Asia Pacific
15.3.11.4.4. Latin America
15.3.11.4.5. Middle East and Africa
15.3.12. Prefilled Syringes Market For Metabolic Disorders
15.3.12.1. Distribution by Type of Syringe Barrel Material
15.3.12.1.1. Glass Barrel Prefilled Syringes
15.3.12.1.2. Plastic Barrel Prefilled Syringes
15.3.12.2. Distribution by Type of Chamber System
15.3.12.2.1. Single Chamber Prefilled Syringes
15.3.12.2.2. Dual Chamber Prefilled Syringes
15.3.12.3. Distribution by Type of Drug Molecule
15.3.12.3.1. Proteins
15.3.12.3.2. Peptides
15.3.12.4. Distribution by Geography
15.3.12.4.1. North America
15.3.12.4.2. Europe
15.3.12.4.3. Asia Pacific
15.3.12.4.4. Latin America
15.3.12.4.5. Middle East and Africa
15.3.13. Prefilled Syringes Market For Other Disorders
15.3.13.1. Distribution by Type of Syringe Barrel Material
15.3.13.1.1. Glass Barrel Prefilled Syringes
15.3.13.1.2. Plastic Barrel Prefilled Syringes
15.3.13.2. Distribution by Type of Chamber System
15.3.13.2.1. Single Chamber Prefilled Syringes
15.3.13.2.2. Dual Chamber Prefilled Syringes
15.3.13.3. Distribution by Type of Drug Molecule
15.3.13.3.1. Antibodies
15.3.13.3.2. Proteins
15.3.13.3.3. Peptides
15.3.13.3.4. Small Molecules
15.3.13.4. Distribution by Geography
15.3.13.4.1. North America
15.3.13.4.2. Europe
15.3.13.4.3. Asia Pacific
15.3.13.4.4. Latin America
15.3.13.4.5. Middle East and Africa
16 GROWTH DRIVERS
16.1. Chapter Overview
16.2. Rising Incidence of Chronic Diseases
16.3. Growing Preference for Self-Injection
16.4. Evolving Patient Demographics
16.5. Growth of Biologics and Biosimilars Market
16.6. Changing Pharmaceutical Strategies
16.7. Increasing Focus on Prevention of Needlestick Injuries
16.8. Prefilled Syringes in Autoinjectors and Pen Injectors
17 SWOT ANALYSIS
17.1. Chapter Overview
17.2. Strengths
17.3. Weaknesses
17.4. Opportunities
17.5. Threats
17.6. Concluding Remarks
18 PREFILLED SYRINGE COMPONENT MANUFACTURERS
18.1. Chapter Overview
18.2. List of Component Manufacturers
18.3. Aptar Pharma (a Part of AptarGroup)
18.3.1. Company Overview
18.3.2. Financial Performance
18.3.3. Product Portfolio
18.3.4. Recent Developments and Future Outlook
18.4. West Pharmaceutical
18.4.1. Company Overview
18.4.2. Financial Performance
18.4.3. Product Portfolio
18.4.4. Recent Developments and Future Outlook
18.5. Datwyler Sealing Solutions (a Part of Datwyler Group)
18.5.1. Company Overview
18.5.2. Financial Performance
18.5.3. Product Portfolio
18.5.4. Recent Developments and Future Outlook
18.6. Lonstroff (a Part of Sumitomo Rubber Industries)
18.6.1. Company Overview
18.6.2. Financial Performance
18.6.3. Product Portfolio
18.6.4. Recent Developments and Future Outlook
18.7. Ompi (a Part of Stevanato Group)
18.7.1. Company Overview
18.7.2. Product Portfolio
18.7.3. Recent Developments and Future Outlook
18.8. Jiangsu Hualan Pharmaceutical New Material
18.8.1. Company Overview
18.8.2. Product Portfolio
18.8.3. Recent Developments and Future Outlook
19 FILL / FINISH SERVICE PROVIDERS FOR PREFILLED SYRINGES
19.1. Chapter Overview
19.2. Fill / Finish Processing of Prefilled Syringes
19.2.1. Steps Involved in Fill / Finish Process
19.2.2. Methods of Filling and Stoppering of Prefilled Syringes
19.2.3. Prefilled Syringe Filling Technologies
19.3. Outsourcing of Fill / Finish Operations
19.4. Growth Considerations
19.5. Prefilled Syringes: List of Fill / Finish Service Providers
19.5.1. Analysis by Year of Establishment
19.5.2. Analysis by Geographical Location of Headquarters and Type of Drug Molecule
19.5.3. Analysis by Scale of Operation
20 CASE STUDY: AUTOINJECTORS
20.1. Chapter Overview
20.2. Autoinjectors: Market Overview
20.3. Key Players
20.3.1. Elcam Medical (E3D Elcam Drug Delivery Devices)
20.3.1.1. Company Overview
20.3.1.2. Product Portfolio
20.3.2. Nuance Designs
20.3.2.1. Company Overview
20.3.2.2. Product Portfolio
20.3.3. Owen Mumford
20.3.3.1. Company Overview
20.3.3.2. Product Portfolio
20.3.4. Scandinavian Health Limited (SHL) Group
20.3.4.1. Company Overview
20.3.4.2. Product Portfolio
20.3.5. Union Medico
20.3.5.1. Company Overview
20.3.5.2. Product Portfolio
20.3.6. Ypsomed
20.3.6.1. Company Overview
20.3.6.2. Product Portfolio
21 CONCLUDING REMARKS
21.1. Chapter Overview
21.2. Key Takeaways
22 INTERVIEW TRANSCRIPTS
22.1. Chapter Overview
22.2. Oval Medical Technologies
22.2.1. Company Snapshot
22.2.2. Interview Transcript: Matthew Young, Founder and Chief Technology Officer
22.3. Intas Pharmaceuticals
22.3.1. Company Snapshot
22.3.2. Interview Transcript: Kirti Maheshwari, Chief Technical Officer
22.4. IDT Biologika
22.4.1. Company Snapshot
22.4.2. Interview Transcript: Gregor Kawaletz, Chief Commercial Officer
22.5. West Pharmaceutical
22.5.1. Company Snapshot
22.5.2. Interview Transcript: Kevin Cancelliere and Tibor Hlobik, Marketing Directors
22.6. Lonstroff
22.6.1. Company Snapshot
22.6.2. Interview Transcript: Marco Pederiva, Marketing and Sales Directors
22.7. IDEO
22.7.1. Company Snapshot
22.7.2. Interview Transcript: Jesse Fourt, Design Directors
22.8. Small-sized Medical Device Company
22.8.1. Interview Transcript: Anonymous, Chief Executive Officer
23 APPENDIX 1: TABULATED DATA
24 APPENDIX 2: LIST OF COMPANIES
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
ben.johnson@rootsanalysis.com
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
(Added: Wed Oct 20 2021 Hits: 19 Rating: 0.00 Votes: 0) Rate It
- 4th Annual Pharma Supply-Chain & Security World 2022
- The Annual Pharma Supply Chain and Security World Summit is a major global event for the pharmaceutical industry, bringing together the whole Pharma Supply Chain community for two days of discussion on new developments, technologies, strategies and best practices to ensure an agile, responsive, streamlined and a secured supply chain. The pharmaceutical supply chains are facing a significant challenge in the form of counterfeit drugs that are entering the supply chain from various points at different levels. Pharmaceutical companies that adopt an effective serialisation program have end-to-end visibility and traceability for all of their packaging, labelling, and distribution. This enables them to rapidly identify and quarantine counterfeit products. This helps to protect patients, consumers worldwide, brand equity, reputations and the company's revenue stream by ensuring compliance with regulatory requirements for serialisation of medicines in emerging markets. The rise of the digital supply chain has been accompanied by an ever-increasing number of regulations that have accelerated its development and adoption. Years ago, the pharmaceutical supply chain regulated only manufacturing and distribution. However, with a rise in economic impact of counterfeit drugs on society, there have been attempts to improve serialisation processes even further.
In spite of past obstacles, innovations like IoT, AI and ML (and Blockchain) have led us into an exciting era of digitization within our industry. Data-driven algorithms and analytics will transform the pharmaceutical supply chain, helping it become more intuitive. With AI's predictive power combined with ML capabilities to analyse data in a speedy fashion, pharma companies can use this information towards making smarter decisions that lead to greater success throughout all stages of their operations. Combining AI with other advanced technologies, such as blockchain, can create a system that is immutable and transparent. This will also allow for the security of products to be improved in the long run by shielding from counterfeit drugs or substandard medicines.
Corvus Global Events invites you to 4th Annual Pharma Supply Chain & Security World 2022 - Supply-chain, Drug Serialization and Anti-Counterfeiting conference, which will have Pharma industry experts sharing various challenges faced, new strategies, case studies and use of innovative ideas, the conference will also offer opportunities to encourage partnerships and collaborations. In this conference you’ll not only discover innovative technologies, transformation strategies and collaboration methods, but how best to implement them to optimise your supply chain processes and strategies for drug anti-counterfeiting.
It gives us a great pleasure to welcoming you to the 4th Annual Pharma Supply Chain & Security World 2022.
Key Highlights
Streamlining your supply chain
End to End supply chain visibility
Designing an optimal supply chain network
Strategies for drug anti-counterfeiting in global supply chain and improving security through an interlinked supply chain strategy
Developing a sustainable Serialization strategy
Integration of track & trace solutions in production and supply chain
Smart Packaging, Labelling and Artwork
Warehouse & Logistics
Serialization Data and Analytics driven approach to increase supply chain agility
Adoption of Blockchain in pharma supply chain
Intelligent Automation enabling Industry 4.0
The need to understand and adopt new technologies like IoT, Analytics, Machine Learning and Artificial Intelligence
Effective Authentication Technologies
Best selection of tamper-evident features
Brand Protection & Securing supply chain integrity
Global enterprise level solutions for anti-counterfeiting
Tackling pharmaceutical crime - initiatives at multinational, EU and national level
IP and regulatory enforcement
Synchrony of the Pharma Industry and professional bodies against counterfeiting
Understanding and meeting the needs of DSCSA, EU FMD and other global regulations
Strategies for public awareness and patient protection
Best practices to protect your brand
The role of the Internet in aiding the counterfeiters – How to overcome the situation?
How Pharma Industry and professional bodies are fighting against counterfeiting
Developing a RMP for your supply chain to protect your Brand, Product and Patient Safety
Case study: How companies are structuring their counterfeiting efforts and departments?
Who should attend the conference?
Attendees include GMs, VPs, Directors, Heads and Managers of:
Pharmaceutical manufacturers and distributors
Supply Chain management companies
Serialization, Track and Trace solution providers
Packaging & labelling
Authentication technology suppliers
Operations/Portfolio management
Production process
Quality/Compliance Management
Manufacturing Automation
Digital Innovation (Block Chain, AI, ML)
Data Analytics
Contract manufacturing organisation (CMO)
Contract packaging organisation (CPO)
Brand protection, enforcement, security, integrity and management companies
Healthcare research organizations
Pharmaceutical industry professional associations
Anti-counterfeiting organizations
IT service providers
Cloud & Big Data
Intellectual Property, investigators and Trademark council
Drug regulatory agencies and customs
Pharmacists
(Added: Tue Oct 19 2021 Hits: 21 Rating: 0.00 Votes: 0) Rate It
- Virgin Coconut Oil Market Demand, Size, Share and Global Analysis, 2027 | MRFR
- Virgin Coconut Oil Market is Expected to Grow at a CAGR of 9.8% from 2017 to 2023 :
Pune, India, August 22, 2017/MRFR Press Release- Market Research Future published a Half Cooked Research Report on the Global Virgin Coconut Oil Market, which is estimated to grow at the CAGR of 9.8 % during the forecast period of 2017-2023
Market Overview
Coconut oil is an edible oil extracted from the kernel or meat of the matured coconuts. Indonesia and Philippines are the two key coconut producers across the globe and India holds the third place in the global market. The coconut oil has significant usage in personal care, food, and various industrial sectors. Apart from this, it is also utilized in the healthcare industry, especially, by diabetic patients as it helps in appropriate utilization of blood glucose. Besides ordinary coconut oil that is extracted from coconut, there has been an increase in the demand for virgin coconut oil. The virgin coconut oil is extracted from the fresh coconut milk procured from 12 months of pollination of coconut either by natural or by mechanical techniques. It is a rich source of fatty acids and it includes various nutrients such as vitamins, minerals, and antioxidants. Chemical processing, or bleaching is avoided in the extraction of virgin coconut oil. This product is gaining grip across the world as a nutraceutical food oil and is getting popular amongst health conscious people.
Market Forecast
The global virgin coconut oil market is expected to be driven by the rising prevalence of diseases among the consumers both in the developed and developing economies which is enforcing consumers to shift towards healthy and nutritional food consumption. Virgin coconut oil is expected to experience the high demand from consumers owing to increasing health consciousness as well as aging population. Also, increasing consumer expenditure on functional food and beverages as well as health benefits in terms of proper nourishment of skin and hair is estimated to strengthen the demand for virgin coconut oil over the forecast period.
Increasing consumption of omega fatty acid will generate more demand for virgin coconut oil. The market players are responding to these new opportunities by expanding their service offerings and product lines, which has fueled up the share of virgin coconut oil in the global market. High nutritional benefits such as vitamins, minerals, antioxidants, and others obtained from this product are also supporting the sale of virgin coconut oil globally. Additionally, the augmentation of the product development together with research advancements are other significant reasons for the increasing growth of virgin coconut oil market. Hence, along with changing consumer preferences, the growth of global virgin coconut oil market expected to increase significantly during the forecast period 2017-2023.
Access Report Details @ https://www.marketresearchfuture.com/reports/virgin-coconut-oil-market-4130
Downstream Market Analysis
The virgin coconut oil market is highly fragmented due to existence of numerous small and large vendors. The global virgin coconut oil market is estimated to experience rapid change in consumer demands and preferences. Furthermore, the popularity of virgin coconut oil and involvement of nutritional attributes are also encouraging the growth of this market. Rising demand for natural products is expected to play a significant role in the market growth during the forecast period. Additionally, the augmentation of the product development together with research advancements will play a major role in the growth of the global virgin coconut oil market over the review period.
Competitive Analysis
Some of the Key Players in the Global Virgin Coconut Oil Market are
• Barlean's (U.S.)
• Hain Celestial (U.S.)
• Nutiva, Inc. (U.S.)
• Healthy Traditions (U.S.)
• NMK Holdings (Pvt) Ltd. (Sri Lanka)
• Greenville Agro Corporation (Philippines)
• SUN BIONATURALS (INDIA) PRIVATE LTD. (India)
The demand for virgin coconut oil has pushed manufacturers to innovate and develop new product lines that are better in taste and offers various health benefits.
Regional Analysis
The global virgin coconut oil market is regionally segmented into North America, Europe, Asia Pacific, and Rest of the World (RoW). Asia Pacific accounted for the largest revenue share in virgin coconut oil market globally and is estimated to retain its dominance in the market during the forecast period 2017-2023. The region is the largest producer and exporter of virgin coconut oil across the globe. About 60%-70% of value addition in coconut oil is happening in Philippines, which will help the market to grow over the forecast period. Asia Pacific is followed by North America due to the new product development by the key manufacturers of virgin coconut oil, which is projected to be one of the significant reasons for the rising growth of virgin coconut oil products. However, Asia Pacific region is estimated to witness a maximum growth in the global virgin coconut oil market over the forecast period 2017-2023.
Market Segmentation
Global Virgin Coconut Oil Market is segmented by Type, Application, Distribution Channel and Region.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com
(Added: Tue Oct 19 2021 Hits: 20 Rating: 0.00 Votes: 0) Rate It
- Common Questions about Ceftriaxone tablets
- Ceftriaxone is an antibiotic that is used to treat a number of bacterial illnesses. Ceftriaxone is a cephalosporin antibiotic, which means it belongs to a group of antibiotics known as cephalosporins. It is effective to prevent the growth of bacteria inside the body.
Centurion Healthcare is a distinct Ceftriaxone tablets supplier in Gujarat.
Because of the increased risk of side effects, ceftriaxone is not indicated for use in babies with high blood bilirubin levels or preterm infants..
Centurion Healthcare is an excellent and reputed Ceftriaxone tablets supplier in Vadodara.
Ceftriaxone can also be administered prior to dental treatments in persons who have specific heart issues (such as prosthetic heart valves) to assist prevent significant heart infection (bacterial endocarditis).
Centurion Healthcare is the most popular Ceftriaxone tablets supplier in Gujarat.
Q. When do Ceftriaxone starts working?
Ceftriaxone usually begins to function soon after you take it. However, killing all of the bad germs and entirely relieving your symptoms may take a few days.
Centurion Healthcare is a noted Ceftriaxone tablets supplier in Vadodara.
Q. Who must not consume Ceftriaxone?
Ceftriaxone or any of its constituents should not be prescribed to those who are allergic to them. If you have or have ever had problems with your liver, kidneys, gall bladder, or any other blood-related conditions such as hemolytic anaemia, tell your doctor. To avoid any adverse effects on the baby, do not use Ceftriaxone without consulting your doctor if you are pregnant, breastfeeding, or planning a baby. Tell your doctor about all other medications you're taking, as they may interact with or be affected by this one.
(Added: Tue Oct 19 2021 Hits: 10 Rating: 0.00 Votes: 0) Rate It
- Ready-to-Eat Meals Market Size, Share, Growth, Global Analysis, 2027 | MRFR
- Market – Overview
Ready to eat meals have emerged as the next big trend in the food and beverage sector. The market has developed rapidly due to the prevalence of a fast paced lifestyle, especially in urban areas. Market Research Future, which focusses on market reports associated to Food, Beverages & Nutrition sector among others, have lately made available a report on this industry. The sector is expected to grow at a CAGR rate of 6% approx. from the year 2016 to 2022.
Amplified development in terms of food preparation and processing have been a positive stimulant to the expansion of the market. Heightened preference of working professionals for easy to make meal options has fuelled the evolution of the market at a swift pace. Health based meals have also been of the quickly growing areas of the market as individuals are on the lookout for meals that are precooked.
Industry Segments
The market for ready-to-eat meals has been divided on product types into bakery, ready meals and mixes, non-alcoholic beverages, herbs and spices, soups, noodles and pasta among others. The packaging segment of the industry includes of box, can, vacuum pack sachet, bag and others. The cuisine type divides the market into Italian, Indian, Continental, Chinese and others. The specialty type segment of the market is categorized into preservative free, vegetarian, natural, non-vegetarian and others. The form segment divides the market into frozen, dried, cooked, instant, fresh and others.
Detailed Regional Analysis
The industry for global ready to eat meals is divided into Europe, North America, Asia Pacific, and Rest of the World (RoW). Among the different regions, the North American region has the main market share trailed by Europe and Asia Pacific. Rising population and increase in disposable income in Asia Pacific region is boosting the demand for ready to eat meals in this particular region.
Access Report Deatails @ https://www.marketresearchfuture.com/reports/ready-to-eat-meals-market-1979
Global Competitive Analysis:
With the entrance of new companies, existing companies are trying to achieve an extensive share of the industry share urgently with operative business plans that can fill the void and settle the dynamics of the rivalry in the market. The segment players are trying to attain a huge share in the market segment, which is quickly – evolving. Solid growth trends have also been perceived for the industry with the development of diverse assortments of products. The best growth opportunities for the long term in this sector can be captured by warranting ongoing process improvements and financial elasticity to capitalize on optimal strategies.
The important players profiled in the market for ready to eat meals are Bakkavor Group Ltd (U.K.), Premier Foods Group Ltd (U.K.), General Mills (U.S.), (British Virgin Islands), Nomad Foods Ltd and McCain Foods (Canada) to name a few.
Latest Industry News:
Jan 2018 Anoki, Nottingham’s Indian restaurant has fashioned a range of ready to eat meals for consumers to eat at home or as per their convenience. They have debuted the new variety of pre-cooked meals after an enormously positive pilot scheme last year. The range comprises few of the restaurant’s best and popular dishes, with an assortment of seven main courses, starters, naan breads and rice. The meals are prepared fresh every day by the chefs.
Jan 2018 Plate Up which is a new ready to eat meal brand aims to service New Zealanders who want to consume healthy food, but have time on hand to cook. The firm will contend in an already swarming convenience food industry with the brands like Woop, FoodBox and My Food Bag. There are five prepared meal services that can be home-delivered operating in the market, though they only deliver ingredients.
Jan 2018 The plant-based food business, Urban Remedy which concentrates on organic snacks, cold pressed juices and meals which are ready-to-eat meals, has sealed a main investment from 301 INC of $17m series B fundraising round. The company which acquired Urban Remedy is General Mills’ venture arm entity. Their kiosks are their rapidly developing operation.
(Added: Tue Oct 19 2021 Hits: 10 Rating: 0.00 Votes: 0) Rate It
- Acetaminophen and its directions to use
- Acetaminophen, often known as paracetamol, is a medicine used to treat minor discomfort, such as headaches and joint and muscle pain, as well as to lower fever. Acetaminophen is the main metabolite of the analgesic (pain-relieving) medicines acetanilid and phenacetin, which were once widely used. Acetaminophen relieves pain by raising the pain threshold in the body, and it reduces fever by acting on the brain's temperature-regulating centre. In the central nervous system, the medication suppresses prostaglandin synthesis, but it has a little anti-inflammatory impact on peripheral nerves.
Acetaminophen is less likely than aspirin to have gastrointestinal adverse effects, but it might cause deadly liver damage if taken in excess.
Farmson is a noted and distinguished Acetaminophen USP supplier in Latin America.
Directions to use Acetaminophen:
Acetaminophen is available in a number of brands and dosage forms. Because the amount of acetaminophen in each drug varies, read the dosage recommendations for each product carefully.
Farmson is an excellent and reputed Acetaminophen USP exporter in Latin America.
If you're giving acetaminophen to a youngster, make sure it's a child-friendly version. Use the weight of your child to calculate the proper dose on the product container. If you don't know your child's weight, you can substitute their age.
If the drug is a suspension, give it a good shake before each dose. Some liquids don't need to be shaken before use. Follow the product's directions to the letter. Use the provided dose-measuring spoon/dropper/syringe to measure the liquid medication to ensure you have the right dose. Use a special spoon for this.
Before ingesting with or without water, chew or allow rapidly dissolving tablets to dissolve on the tongue. Before swallowing chewable tablets, chew them well.
Farmson is a prominent Acetaminophen USP supplier in Latin America.
Crushing or chewing extended-release tablets is not recommended. As a result, the medicine may be released all at once, thus increasing the risk of side effects. Do not divide the tablets unless your doctor or pharmacist directs you to do so.
The dose of effervescent pills should be dissolved in the specified amount of water and then consumed.
Farmson is the most popular & distinct Acetaminophen USP exporter in Latin America.
When pain killers are administered as soon as the first signs of pain arise, they work best. The drug may not be as effective if you wait until the symptoms appear.
If you have a fever, don't take this medicine for longer than three days unless your doctor says so. Unless otherwise directed by a doctor, adults should not use this product for more than 10 days (5 days for children). If your child has a sore throat, see a doctor immediately away (especially if he or she has a high fever, headache, or nausea/vomiting).
(Added: Tue Oct 19 2021 Hits: 15 Rating: 0.00 Votes: 0) Rate It
- 11 Waist Trainers You Can Get From Waist Me Up With Big Discount and Free Delivery
- Conscious about your body figure? Want to flaunt a slimmer or a curvier version of yourself? Wearing a top-quality waist trainer is a highly recommended solution. In Australia, Waist Me Up remains the leading shop of premium quality shapewear.
Score any of their top 11 trainers at discounted prices and have it delivered to your home — for free.
Kardashian Latex Waist Trainer
Original Price: $149.95
Discounted Price: $69.95
Suitable for people with a regular or a long torso, this waist trimming undergarment has three layers of Latex core material with cotton lining. It’s easily adjustable and is perfect for everyday use or when you’re engaging in a sports activity.
Latex Waist Trainer with Zip
Original Price: $179.95
Discounted Price: $89.95
If you want a waist trainer Australia that’s easy to wear, this is the item for you. It has nine steel bones with hook-and-eye closures for a more secure hold. Though its outer material is Latex rubber, its inner soft cotton material can assure your comfort. It’s ideal for everyday use, gym workout, and even for pregnancy recovery.
Tummy Flattening Waist Wrapping Belt
Original Price: $69.95
Discounted Price: $39.95
This abdomen trimming belt is available in four sizes: 3, 4, 5, and 6 metres. It’s elastic, comfortable to wear, and is recommended for postpartum recovery.
Lightweight Neoprene Waist Trainer with Double Clinching Belts
Original Price: $59.95
Discounted Price: $29.95
Made of 80% neoprene and 20% nylon, this double belt tummy control gives firm pressure on your abdomen area. It also aids in improving your posture when regularly worn.
Tummy Flattening Waist Cincher Belly Control Panty
Original Price: $89.95
Discounted Price: $49.95
Featuring a sultry thong design, this undergarment flattens your tummy, slims down your waist, and enhances your buttox area.
Breathable Everyday Waist Trainer
Original Price: $79.95
Discounted Price: $39.95
Made from soft nylon/Spandex fabric, this breathable and elastic waist trainer is the ideal everyday companion. Its three-row hook-and-eye design provides different levels of compression, depending on your goals.
Hourglass Waist Trainer Fitness Belt
Original Price: $99.95
Discounted Price: $69.95
A regular at your local gym? You can complement your workout exercises with this waist training fitness belt that offers extreme support. It also minimises your risk of injury.
Ultra Tummy Flatenning & Butt Lifting Bodysuit
Original Price: $174.95
Discounted Price: $79.95
This bodysuit is made from breathable Italian fabric. It’s highly recommended for its superior tummy control capability. Not only that, it can also lift your bust and butt to give your body more curves.
Ultimate Waist & Thigh Fat Burning Belt
Original Price: $129.95
Discounted Price: $69.95
This fat burning belt’s target is to reduce the appearance of cellulite in your waist and thigh. It’s also butt lifting and is great for working out. It’s equipped with adjustable straps for a perfect fit.
Waist Me Up Butt Lifter Shorts
Original Price: $69.95
Discounted Price: $39.95
This open bottom shorts won’t only help you achieve a rounded rear, but it also aids in shaping your hips and thighs. It has a cotton internal lining to give you comfort while wearing it.
Tummy & Waist Slimming Leggings
Original Price: $129.95
Discounted Price: $69.95
These high-waist slimming leggings are comfortable to wear. It’s highly effective in shedding extra fat off your tummy and waist.
Shop the Best Waist Trainer Australia Today
Australia-based Waist Me Up offers premium waist training garments at competitive prices. Browse through their catalogue here: https://waistmeup.com.au. For orders and other queries, call them at 02 8036 6669 or email them at sales@waistmeup.com.au.
(Added: Tue Oct 19 2021 Hits: 14 Rating: 0.00 Votes: 0) Rate It
- Gout Treatment Specialist in Warangal
- Gout is a chronic auto inflammatory disease with regular acute flares which causes severe pain and joint inflammation. It mainly occurs due to high content of uric acid in the blood, this leads to accumulation of uric acid crystals in the joints and surrounding tissues that causes inflammation. It is a type of arthritis that affects the common joints such as big toe, ankle and knee.
Causes of Gout:
It is caused by excess uric acid in the body that leads to the development of monosodium urate crytal deposits in the joints.
Uric acid is a natural waste product that generates from the foods that contain purines. In a normal person uric acid is flushed out through the kidneys and passes out in urine. If you consume foods which are high in purine, your body sometimes cannot get rid of this by-product and uric acid will build up in the blood. When the level of uric acid is high it is known as hyperuricemia and it may lead to the gout.
Gout is caused by different factors such as diet, genetics, obesity, stress, high consumption of alcohol, medications. It also happens with people who have other healthy issues like diabetics, heart failure, kidney problems, and hypertension.
The extra uric acid forms crystals that are sharp and pokey causes joint pain and swelling.
Symptoms of gout:
Apart from inflammation, swelling and pain, acute gout attacks very fast with intense joint pain within 8 to 12 hours.
Gout first occurs in legs or feet and often affects a single joint mainly the joint of big toe.
You may find redness in the skin over a joint.
Might experience mild fever and chills
You may have pain in your back and side
Gout may also cause kidney stones.
Lumps of urate crystal deposits formed under the skin.
How is gout diagnosed?
Your doctor will ask to do few tests like
Joint fluid tests: a fluid sample is taken from the affected joint and examined under a microscope to find the urate crystals. Some infections may have similar symptoms like gout, in such cases, the doctor may check for bacteria in joint fluid.
Blood test: blood test is done to find out the level of uric acid in the blood. Sometimes these tests are confusing because some patients may have high uric acid level and they never experienced gout. And for some patients they have symptoms of gout but they do not have high level of uric acid.
X-ray imaging: x rays help in finding out if there is any other inflammation in the joints.
Ultrasound and CT scan: this technique is used to detect urate crystal in the joint or in a tophus.
(Added: Mon Oct 18 2021 Hits: 21 Rating: 0.00 Votes: 0) Rate It
- Best doctor for arthritis in Karimnagar
- Rheumatoid arthritis (RA) is an inflammatory arthritis in which joints of the hands and feet, are inflamed, which results in joint pains, swelling and frequent destruction of joints. Small joints of the limbs become painful and have stiffness which persists for about 60 minutes on awakening and after inactivity. Due to weakness, fever and damage to other organs may also occur. RA affects both sides of the body. For example, if a joint is affected in one arm or leg then a similar joint of the other arm or leg will be affected too. This is one of the ways RA is identified by the doctors from other forms of arthritis like Osteoarthritis (OA).
Rheumatoid arthritis develops in about 1% in the whole world’s population. Women are affected 2 times more than men. It appears in the age group between 35 to 50years. A similar disease in children may occur which is known as Juvenile idiopathic arthritis.
The cause of Rheumatoid arthritis is not known, it is considered as an autoimmune disease. The components of the immune system attack the soft tissues and will also attack the connective tissue in other parts of the body such as blood vessels and lungs. Due to this, gradually the bone, cartilage and the ligaments of the joints wear away causing deformity. Many unknown factors like viral infections and smoking play a vital role.
Treatments work best when RA is identified at an early stage, so it’s significant to learn the signs. Read on to acquire all you want to know about RA, from kinds and indications, to home remedies, diets, and other treatments.
Symptoms:
People who have RA may experience these symptoms:
Joint pain, fatigue, Joint tenderness, Joint swelling, redness in joints, Joint stiffness, Loss of joint function, limping, joint deformity, both sides of the joints affected, Anemia, Fever, Depression.
Some may feel tired and weak by afternoon. RA may also cause loss of appetite with weight loss.
The signs and symptoms of RA may vary from person to person. Intense RA symptoms are known as flare-ups, and inactive periods. Other times when symptoms are less is known as remission.
Diagnosis:
The 3 tests which doctors follow to diagnose RA:
Blood tests
X-rays
Examination of fluid joints
It is difficult to diagnose RA at early stages. There is no single test or physical finding to confirm the diagnoses. Your doctor will do a physical check-up of your joints for swelling, redness and warmth. Doctor will also test your reflexes and strength in muscles.
Blood test: The blood tests are done to find the blood levels of rheumatoid factor and Anti –CCP antibodies or C-reactive protein (CRP), ESR or both.
Rheumatoid factor test:
RF is a group of antibodies that attack the affected persons own tissues instead of attacking the harmful bacteria or viruses. If Rheumatoid factor in the blood is high then it means the autoimmune system is acting up. The RF test is mostly associated with RA but isn’t limited to that disease.
Anti – Cyclic Citrullinated protein antibody test (anti-CCP):
This test is done to find out anti-CCP antibodies in the blood. Citrulline is produced naturally in the body as part of the metabolism of the amino acid arginine. Citrulline changes the protein structure and may trigger the immune response, by producing the auto antibodies against joint proteins.
Antinuclear antibody test:
This test is done to find out the amount and pattern of antibodies in the blood that works against your own body (autoimmune reaction).
Erythrocyte sedimentation rate (ESR):
The ESR is high in people who have active rheumatoid arthritis. This test is done to know the level of inflammation and measures the speed of red blood cells settling to the bottom of a test tube containing blood sample. Normally red blood cells settle relatively slow, if they settle faster than normal rate then it indicates the inflammation in the body.
C-reactive protein test:
CRP is a blood test to check the amount of protein called C-reactive protein in the blood. This helps in measuring the general levels of inflammation in the body. Many infections and long term diseases will cause high level of CRP. This CRP test cannot identify the root cause or the location of the inflammation. Other tests are required to understand the actual cause.
(Added: Mon Oct 18 2021 Hits: 23 Rating: 0.00 Votes: 0) Rate It
- Oprah Winfrey Keto EZ Shred - Shark Tank Weight Loss Reviews, Scam
- Digestive health is integral to feeling happy, healthy, and well. I hope you are sufficiently motivated, now let's get started with the specifics of your personal detox diet plan. Consume this mixture 4 times a day for about 4 weeks to cleanse the intestinal tract. Add one teaspoon of sea salt to half liter water and drink it before breakfast .
These include pollutants, synthetic chemicals, heavy metals, and other harmful compounds. To make this juice, combine diced cucumber, a bunch of parsley, half teaspoon grated ginger and 1 teaspoon lemon juice. Blend them all together till it turns into a liquid juice. Add dried chamomile leaves to the water and cover the pan with a lid.
But the basic detox diet is plant-based, deriving proteins and other nutrients from grains, vegetables, fruit, seeds and nuts. Your kidneys filter blood, remove excess water, pass urea , and sends this all out of your body via your urine.
Learn effective ways to relieve stress and anxiety with these 16 simple tips. Prune juice is an effective and low-risk home remedy for treating constipation in toddlers, but shouldn't be given to children younger than 1 year old. Constipation is a common problem after surgery, but there are ways to manage or prevent it. According to research in Microbial Ecology in Health and Disease, an unhealthy microbiome may lead to an increased risk of intestinal disorders.
Listed below are a few detox drinks that will keep you hydrated and act as a temporary weight loss solution. Tomato is a good source of lycopene, which has the potential to aid weight loss. A study conducted by the China Medical University found that tomato juice effectively reduced waist circumference and BMI of 30 young females . Foods high in fiber increase satiety and decrease subsequent hunger .
The patient’s blood pressure may soar or become unstable, she may sweat profusely or develop tremors. Haas says that detoxing can pave the way for changes that go well beyond food, because when you look closely at your relationship to food, other habits tend to surface. So, although detoxing for many is triggered by a wish to lose weight, it can be much more than that.
https://www.supplementz.org/ez-shred-keto/
https://www.supplementz.org/nutraxyn-reviews/
https://www.supplementz.org/keto-1500-pills/
https://www.supplementz.org/keto-strong-reviews/
(Added: Sat Oct 16 2021 Hits: 28 Rating: 0.00 Votes: 0) Rate It
- Best Dentist in Allahabad and Prayagraj | Best Dentist Near Me
- Best Root Canal Treatment in Allahabad by Dr Rishi Raj Who is Highly Respected Qualified Root Canal Treatment Expert. Call 09936978627. Dr. Rishi Raj is the Best Dentist in Allahabad. His Clinic is Known as Best Dental Clinic in Allahabad. He Operates with High Care to all his Patients.
(Added: Thu Oct 14 2021 Hits: 19 Rating: 0.00 Votes: 0) Rate It
- Raleigh Primary Care Provider Explains What Is Preventive Care?
- Durham, NC (pressbox) October 14, 2021 - Imperial Center Family Medicine, a Durham, NC family practice, has recently released a new article that focuses on explaining the details of preventive care. The new article is guided by the preventive medicine experts at Imperial Center Family Medicine who have extensive experience providing patient-focused care. They have created this new article in order to help readers get a better understanding of the value of taking a proactive approach to patient's health.
The team at Imperial Center Family Medicine offers readers some valuable information regarding preventive care and why this novel approach to patient care is severely overlooked. In the article, they explain how preventive medicine is the only approach that uses medicine to prevent illness and disease rather than the more traditional, reactionary approach. They also explain how preventive medicine is an offering that can help patients lead more healthy, fruitful lives while also maximizing the efficiency of any practice.
While this new article focuses on explaining the details of preventive care, Imperial Center Family Medicine's website provides readers with more information regarding their team, experience, as well as a full list of service offerings. Their team of experienced physicians offers primary and preventive services that include routine checkups, disease prevention, on-site lab services, immunizations, cancer screenings, depression management, and more. The people at Imperial Center Family Medicine have been meeting the medical needs of families in the triangle area since 1999. They pride themselves on the quality of care they provide to each of their patients.
With the addition of this new article, the team at Imperial Center Family Medicine hopes that readers will have a better understanding of what preventive care is and why it is important to make it the main focus with your primary care doctor. For more information, reach out to the preventive care leaders at Imperial Center Family Medicine today at 919-873-4437 or visit their website at https://icfamilymedicine.com/. Their offices are located at 4309 Emperor Blvd #125 in Durham, NC, 27703.
###
(Added: Thu Oct 14 2021 Hits: 15 Rating: 0.00 Votes: 0) Rate It
- Everything you need to know about Minimal Invasive Total Knee Replacement
- Total knee replacement (also known as knee arthroplasty) is a frequent orthopaedic treatment performed to replace the knee's damaged or worn surfaces.
To examine and access the joint, the typical approach to knee replacement involves making a long vertical incision in the centre of the knee. A variation on this procedure is minimally invasive total knee replacement. To expose the joint, the surgeon employs a shorter incision and a different, less-invasive approach, with the goal of decreasing postoperative pain and expediting recovery.
The minimally invasive procedure, unlike traditional total knee replacement, is not appropriate for all individuals. Your orthopaedic surgeon will go over the various surgery alternatives with you.
During a knee replacement, the diseased cartilage and bone on the knee's surface, as well as certain soft tissues, are removed. The purpose of knee replacement surgery is to provide the patient with a pain-free knee that allows them to resume daily activities and lasts a long period.
If you are looking for the hospital offering the best Minimal Invasive Total Knee replacement in Vadodara, Gujarat, Vaishvi Hospital is the right place for you.
Minimally invasive knee replacement differs from typical knee replacement in that it employs a smaller incision and less cutting of the tendons and ligaments.
The surgical method for a minimally invasive knee replacement is comparable, but there is less cutting of the tissue surrounding the knee. The artificial implants utilised are identical to those used in regular knee replacement surgery. Specially developed surgical devices, however, are utilised to appropriately prepare the femur and tibia and install the implants.
The incision for minimally invasive knee replacement is typically 4 to 6 inches versus 8 to 10 inches for standard knee replacement. A smaller incision causes less tissue disruption.
The procedure employed to open the knee is less invasive, in addition to having a shorter incision. In general, minimally invasive knee replacement treatments are "quadriceps sparing," which means they prevent harm to the quadriceps tendon and muscles in the front of the leg. Other minimally invasive procedures, termed as "midvastus" and "subvastus," entail tiny muscle incisions but are less invasive than traditional knee replacement. Because the techniques utilised to expose the joint create less muscle damage, it may result in less postoperative pain and a shorter recovery period.
Vaishvi Hospital offers the excellent Cruciate Retaining Knee replacement in Gujarat.
The hospital stay following minimally invasive surgery is comparable to the duration following standard knee replacement surgery. This spans from outpatient (same-day) surgery to a one-to-four day hospital stay. The recovery process is incomplete without physical rehabilitation. Specific exercises will be prescribed by your surgeon or physical therapist to help you regain range of motion and strength.
Is Minimally Invasive Total Knee Replacement for everyone?
Not all individuals are candidates for minimally invasive total knee replacement. Before deciding whether the operation is right for you, your doctor will do a thorough evaluation and weigh various variables.
In general, candidates for minimal incision surgeries are thinner, younger, healthier, and more willing to participate in the rehabilitation process than typical surgical patients.
Minimally invasive operations may be less appropriate for patients who are overweight or have had previous knee surgery.
Vaishvi Hospital uses the widely known Subvastus Approach in Total knee replacement surgery.
Furthermore, individuals with a severe knee deformity, those who are very muscular, and those who have health conditions that may impair wound healing may be at a higher risk for complications with minimally invasive total knee replacement.
(Added: Thu Oct 14 2021 Hits: 16 Rating: 0.00 Votes: 0) Rate It
- Global Hygienic Diaphragm Valves In Biopharma Industry Outlook, Growth Prospects
- The global report titled as Hygienic Diaphragm Valves In Biopharma market has recently published by Absolute Markets Insights to its huge repository. This research report involves massive data which can influence the development of the Hygienic Diaphragm Valves In Biopharma market. This exploration report provides effective data which can act as a guideline for handling the risks and challenges faced in the businesses. It covers the major recent trends that are influencing the growth of the global Hygienic Diaphragm Valves In Biopharma market.
Different leading players have been profiled to get a detailed description of various effective strategies carried out by top-level companies. After studying the key companies, it focuses on the startups contributing to the progress of the Hygienic Diaphragm Valves In Biopharma market.
For more information about this report visit: https://www.industryglobalnews24.com/global-hygienic-diaphragm-valves-in-biopharma-market-
List of Key Players of Hygienic Diaphragm Valves In Biopharma Market: ALFA LAVAL, Aquasyn LLC, Donjoy Technology Co., Ltd., Entegris, FLEXACHEM, Saint-Gobain Performance Plastics, Watson-Marlow Fluid Technology Group, Emerson Electric Co, and INOXPA S.A.U., amongst others.
The COVID-19 pandemic has massively boosted the investment in biopharma sector. The rise in demand for COVID-19 vaccines, coupled with the growth in initiatives to tackle pandemic situations in the coming years has led to the growth in revenue for the biopharma companies. As a result of the same, these companies are increasingly looking towards advancing their infrastructure, and hygienic diaphragm valves is a vital part of the same. These valves help in the prevention of leakage of fluids, which in turn ensures the safety of various advanced processes in the biopharma sector. Furthermore, the market participants can reach more end-users using online sales channels, which have seen an immense growth during the pandemic, thereby increasing the revenue flow in the global hygienic diaphragm valves in biopharma market. Therefore, the market is expected to see considerable growth in the coming years, driven by the rise in demand for hygienic diaphragm valves due to the pandemic situation. Absolute markets insights reported that the global hygienic diaphragm valves in biopharma market is expected to grow at a CAGR of 6.87% over the forecast period (2021 – 2030).
Primary and secondary research techniques have been used by analysts of this research report to examine the market effectively. The research report further concentrates on collecting the historical records of the Hygienic Diaphragm Valves In Biopharma market. Price evaluation has been finished by analysts of this research report. Finally, researchers direct its focus on different vendors, clients, sellers, and manufacturers. In addition to this, it offers some significant drivers, restraints, and opportunities to get insights into the businesses.
Global Hygienic Diaphragm Valves In Biopharma Market Segmentation:
By Component
• Products/Systems
• Services
By Seal Material
• EPDM
• Silicone
• PTFE/EPDM
• TFM/EPDM
• Others
By Operation
• Manual
• Pneumatic
By Type
• Wireless
• Wired
By Valve Configuration
• One Valve
• Two Valve
By Distribution Channel
• Direct
• Indirect
By Region
• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America
Contact Us:
Company: Absolute Markets Insights
Email id: sales@absolutemarketsinsights.com
Phone: +91-740-024-2424
Contact Name: Shreyas Tanna
The Work Lab,Model Colony, Shivajinagar, Pune, MH, 411016
Website: https://www.absolutemarketsinsights.com/
(Added: Wed Oct 13 2021 Hits: 19 Rating: 0.00 Votes: 0) Rate It
- Non-Emergency Medical Transportation Market- Global Opportunity Analysis and Industry Forecast
- The global report titled as Non-Emergency Medical Transportation market has recently published by Absolute Markets Insights to its huge repository. This research report involves massive data which can influence the development of the Non-Emergency Medical Transportation market. This exploration report provides effective data which can act as a guideline for handling the risks and challenges faced in the businesses. It covers the major recent trends that are influencing the growth of the global Non-Emergency Medical Transportation market.
Different leading players have been profiled to get a detailed description of various effective strategies carried out by top-level companies. After studying the key companies, it focuses on the startups contributing to the progress of the Non-Emergency Medical Transportation market.
For more information about this report visit: https://www.absolutemarketsinsights.com/reports/Non-Emergency-Medical-Transportation-Market-2019-2027-419
List of Key Players of Non-Emergency Medical Transportation Market: ABC Non-Emergency Medical Transportation, LLC, Acadian Ambulance Service, Access2Care, ALC., Ecolane, ERS Transition Ltd, Express Medical Transporters, IU Group, LogistiCare Solutions, LLC, and London Medical Transportation Systems, Lyft, Inc., Uber Technologies Inc., amongst others.
Several countries around the globe have a 24*7 helpline for emergency medical services. Non-emergency medical care is an attractive market that is seeing a significant growth during the last few years. The unavailability of vehicles or the inability to use vehicles during certain conditions drives the citizens towards non-emergency medical transportation (NEMT) services. Progression in internet technology coupled with the proliferation of smart devices has allowed the NEMT service providers to reach more customers through mobile applications. Uber Technologies Inc., for instance, has introduced their Uber Health program in the U.S. that caters to the needs of the general population. Transportation services can be availed on demand using this platform. Furthermore, the rise in the geriatric population plays a significant part in the growth of the global non-emergency medical transportation market.
According to the United Nation’s World Population Prospects 2019, around 17% of the global population will be above the age of 65 in 2050, as compared to the 9% mark in 2019. In Europe and the U.S., the figure could be as high as 25%. Those above the age of 80 is expected to show a 200% growth by 2050. Old age may bring along several issues such as ailing bone health, arthritis, loss of vision, and respiratory illness, amongst others. All these can lead to the loss of driving ability. The geriatric population, therefore, may depend on NEMT services for regular health check-ups, dialysis, rehabilitation visits, etc.
Global Non-Emergency Medical Transportation Market Segmentation:
By Service Type
o Private Pay Patient Transportation
o Insurance Backed Patient Transportation
o Courier Services
o Transportation Management and Optimization
By Application
o Dialysis
o Routine doctor visits
o Mental health-related appointments
o Medical specialist visits
o Rehabilitation
o Testing/screening-related appointments
o Chemotherapy
o Others
By Age Groups
o Below 20 years
o 20 to 60 years
o 60+ years
By Region
o North America
o Europe
o Asia Pacific
o Middle East and Africa
o Latin America
Contact Us:
Company: Absolute Markets Insights
Email id: sales@absolutemarketsinsights.com
Phone: +91-740-024-2424
Contact Name: Shreyas Tanna
The Work Lab,Model Colony, Shivajinagar, Pune, MH, 411016
Website: https://www.absolutemarketsinsights.com/
(Added: Wed Oct 13 2021 Hits: 14 Rating: 0.00 Votes: 0) Rate It
- Global Environmental Health and Safety Software Industry Outlook
- According to new informative report by Absolute Markets Insights an analytical data of Environmental Health and Safety Software market has recently added to its massive database. The research report is encapsulated different verticals of the businesses. It has been aggregated on the basis of different dynamic aspects of the businesses. This statistical report has been compiled by using primary and secondary research methodologies. Well, explained Porter’s five analysis and SWOT analysis have been used to examine the strength, weaknesses, threats and opportunities.
The competitive landscape of the Environmental Health and Safety Software market has been provided by analyzing different successful and startups industries. The economic aspects of the businesses have been presented by using facts and figures. This research report covers North America, Latin America, Asia-Pacific, Europe and Africa on the basis of productivity. It focuses on the leading countries from the global regions. This report highlights the cost structure including cost of raw material and cost of manpower. It offers a clear picture of the various factors that will fueling the growth of Environmental Health and Safety Software market.
Top Players of Global Environmental Health and Safety Software Market are Studied: Some of the prominent players operating in the Environmental Health and Safety Software Market include IBM Corporation, SAP SE and Sphera amongst others.
For more information about this report visit: https://www.absolutemarketsinsights.com/reports/Environmental-Health-and-Safety-Software-Market-2019-2027-278
Key Findings of the Report:
• Government agencies shoulder the crucial responsibility of making rules with regards to safety standards and workplace compliance. The adoption of EHS by government offices and branches for creating and monitoring safety regulations at workplace is augmenting the Environmental Health and Safety Software Market growth.
• The modular solutions offered by EHS software such as medical and occupational health, environment and waste management, industrial hygiene and safety, in addition to compliance and risk management is being adopted as a unified mechanism to customize data for a specified area. This indicates potential growth opportunity for the market.
Global Environmental Health and Safety Software Market
By Deployment
o Cloud Based
o On Premise
By Verticals
o Manufacturing
o Oil and Gas
o Chemical
o Energy and Utilities
o Mining
o IT and Telecommunication
o Others
By Organization Size
o Small and Medium Sized Enterprises
o Large Enterprise
By Region
• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America
Contact Us:
Company: Absolute Markets Insights
Email id: sales@absolutemarketsinsights.com
Phone: +91-740-024-2424
Contact Name: Shreyas Tanna
The Work Lab,Model Colony, Shivajinagar, Pune, MH, 411016
Website: https://www.absolutemarketsinsights.com/
(Added: Wed Oct 13 2021 Hits: 13 Rating: 0.00 Votes: 0) Rate It
- Best Hospital in Kasaragod - Doctors Hospital
- Hospitals are institutions which deals with health care activities. Doctors Hospital offer treatment to patients with specialized equipment. We serve humanity and play a vital role in the social welfare of any society. We have all the facilities to deal with varying diseases to make the patient healthy. The main aim of Doctors hospitals is the Best Hospital in Kasaragod which offer maximum health services and ensure care and cure.
(Added: Tue Oct 12 2021 Hits: 16 Rating: 0.00 Votes: 0) Rate It
Pages: [<<] ... 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 ... [>>]
Links SQL By: Gossamer Threads Inc.
